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Chapter 1 
INTRODUCTION 
1.1 Developments in clinical chemistry 
Clinical chemistry is the science occupied with the analysis of chemical constituents in 
body fluids and with conversion of the resulting data into information with a higher 
abstraction level. The developments in clinical chentistry in the last decades have 
occurred in rapid succession. Improvements in technology permitted the introduction of 
autoanalyzers, thereby allowing an immense increase in capacity of the clinical 
laboratory. With the expansion of biochemical research, a growing interest in the 
diagnostic possibilities ensued, resulting in a steady increase in daily workload. From the 
clinical chentistry laboratory of our hospital with 1000 beds, every day approximately 
8000 analytical results are transmitted from the laboratory to the clinic. Developments in 
computer technology enabled a more practical handling of the increased flow of data. 
These data can be automatically transmitted from the laboratory to the clinic, and they 
can be stored and accumulated to large sets for later inspection. These data provide 
information when interpreted against reference ranges, taking their interdependency into 
account, and when interpreted in relation to the clinical picture. Attempts have also been 
made toward the interpretation of laboratory data leading to laboratory diagnoses. 
1.2 Reference ranges 
Laboratory data are interpreted primarily against a range of values that are found in 
healthy control subjects (!). Generally, a 95% confidence interval obtained from 
measurements in material from such control persons is used as the reference range. This 
interval is often calculated assuming a Gaussian distribution. 
Some criticism may be given concerning this approach. Not all analytes follow a 
Gaussian distribution curve (2,3). Furthermore, there are many factors that may influence 
the reference range. For many analytes there is a variation in reference range with sex 
and age. The concentration of some analytes depends on the posture of the body, e.g. the 
serum total protein concentration is !mown to decrease by 12% if the patient is allowed 
to lie down for half an hour (4). Some analytes follow a circadian rhythm. By 
consequence, the sa..mpling time is important in the interpretation of the result. The 
concentration of some analytes is influenced by diet. 
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In the light of these comments, the determination of reference intervals from the hospital 
population seems advantageous. In this case, the important assumption is made that the 
majority of laboratory results is not pathological, even though it has been obtained from 
a patient population subject to pathology. Although this presupposition has been adopted 
by many without much comment, it seems important to fmd the reason for this 
paradoxical situation. The central part of a sufficiently large number of patient results 
often follows a Gaussian distribution. This central Gaussian part is not likely to be 
characterized by a very pathological mean value. There are several arguments to support 
this postulate. Experience learns that usually a considerable part of all measurements is 
within the normal range. Furthermore, if ouly the central Gaussian part of the patient 
population is selected for the calculation of the reference range, there is no interference 
from extreme pathological values. The less extreme values at both sides of the central 
part will influence the calculated mean and standard deviation. If these values at both 
sides of the central part are asymmetrically distributed, they will not pass the test for 
Gaussian behaviour and hence be excluded from calculation (i.e. no influence). If they 
are symmetrically distributed, they will annihilate each others influence on the mean 
value, but they will still have an upward effect on the calculated standard deviation. The 
shift of the mean of the central part away from the normal range, will be discussed later 
(ch. 5). A prerequisite to the approach mentioned above is that the size of the Gaussian 
fraction should be sufficiently large to enable its mathematical separation from the 
pathological fraction. By this approach, the continuous monitoring of the reference values 
obtained from the hospital population is obligatory. With a drift in age distribution for 
instance, it seems likely that the reference range should be adjusted accordingly (5). 
However, this is not a decisive argument against the use of patient-based reference 
ranges, because in the conventional approach (healthy reference subjects) a re-evaluation 
Vlith an adjusted age distribution would be just as necessary. 
1.3 Multivariate analysis 
In general, the calculation and application of reference values has been done in an 
univariate manner. The result of a single analysis is interpreted against a •silver' standard, 
being the reference range of the laboratory where the analysis is done. 
When the results of two types of analysis A and B, obtained with the same sample, are 
taken into account simultaneously, cases occur for which the results fall within the 
reference range for analysis A, but outside the reference range for analysis B, and vice 
versa. In this way, the fraction of normal individuals that have both analyses within their 
reference range is smaller than the fraction that has only one within range. When more 
types of analysis are considered together, the fraction of normal individuals having all 
values within range decreases rapidly. It can be calculated, assuming 95% reference 
ranges, that only 77% of normal individuals will have all their values within range when 
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five types of uncorrelated analyses are considered together. 
When two correlated analyses are considered together, the reference range becomes an 
ellipse, of which the shape and orientation is dependent on the correlation coefficient (fig. 
1.1). 
B 
~:------
A 
Figure 1.1 Univariate and multivariate reference ranges. 
For those analyses that are strongly correlated, the ellipse becomes shallow and will 
evenmally become a straight line. In this hypothetical situation a measurement of A 
means that B can be calculated from the relation. In the complementary situation with a 
very weak correlation between A and B, the shape of the ellipse approaches a circle 
(provided that A and B have been normalized by division by their respective standard 
deviation). In this situation, the use of multivariate analysis is of little value because the 
number of patient results that are outside the circle will not be very different from the 
number being outside the square formed by both univariate reference ranges. Put in 
another way, a multivariate approach is advantageous with parameters havillg a tight 
correlation, because there is a larger area where abnormalities may be signalled. Although 
the probability to fmd such a result is likely to decrease with increasing correlation 
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coefficient, the information contained in such a combination has either pathological or 
analytical significance. In chapter 5 we will further expand on this matter. 
1.4 Information enhancement in clinical chemistry 
Generally, laboratory tests are requested for either diagnosis, monitoring of the patients 
functions or therapy. The results are objective data that reflect the current condition of 
the patient. These data are subject to some amount of variation from the pre-analytical 
phase and to a known measurement error. 
In contrast, clinical information is of a much more subjective nature, with an exception 
for information that can be obtained by measurements (e.g. pulse rate or body 
temperature). Because the signs and symptoms of disease are the result of complex 
multifactorial processes, the application of clear-cut rules laid down in algebraic formulae 
in this field is an impossibility. 
Many clinical chemistry variates are subject to physical and chemical laws, e.g. the 
principles of electroneutrality (reflected in the anion gap, refs.6,7) and iso-osmolality 
(reflected in the osmolality gap, ref.8), the pH-dependent binding of calcium to the 
plasma proteins, and the Henderson-Hasselbalch equation governing the acid-base 
equilibrium. Several of these formalizations rely on the assumption of an equilibrium 
situation and a system free from interfering compounds. In systems with compartmentali-
zation, progressive complexity, and dynamic behaviour, the application of these principles 
becomes increasingly difficult. 
Nevertheless, clinical chemistry analyses provide a wealth of basal, bard-core data, that 
can be combined to yield information of a higher abstraction level. This transformation 
can be done by expert systems (see section 1.6) incorporating a mixture of pattern 
recognition, numerical formula evaluation, and reasoning based on physiological 
principles. For instance, in analyses of creatinine and urea in 1488 sera, only 4 out of the 
9 (32) possible patterns occurred consistently when both analytes were classified as low, 
normal, or high. In the same study, 7695 sera were evaluated for sodium, potassium, 
chloride, and bicarbonate, and of the 81 (34 ) possible patterns, only 41 were actually 
observed (9). Unusual patterns may serve to detect laboratory error, or to attend the 
physician to an exceptional situation. Multivariate analysis of large data sets can provide 
statistical information that can be .incorporated .in expert systems. For instance, the 
probability may be calculated that a certain pattern is associated with a certain disease. 
The enhanced information produced from clinical chemistry analyses must serve as a 
functional support to the physician in the diagnostic process or in the monitoring of the 
patients condition or therapy. 
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1.5 The need for interpretative reporting 
In one study, 71% of the physicians questioned believed they did not require computer 
assistance for acid-base analysis. However, when actually tested, they were able to 
correctly identify only 39% of acid-base problems (10). In another study, the correct 
response rates of21 physicians to single, double, and triple acid-base disorders were 86%, 
49%, and 17%, respectively (11). In a study on the diagnosis of anemia, abundant 
laboratory data were found (i.e. normal vitamin B1,tfolate levels in iron deficiency 
anemia) that wonld be considered redundant retrospectively (12). 
In several other srudies, a number of cases occurred in which physicians had to admit that 
the computer interpretation was correct and they adjusted their diagnosis accordingly 
(13,14). 
1.6 Expert systems 
1.6.1 Definition 
According to an often used definition, an expert system is a computer program that can 
give advice in a well-defmed area of expertise and should be able to explain its line of 
reasoning. 
1.6.2 History 
Because the development of expert systems has its roots in artificial intelligence, the 
development of the frrst expert systems originated at large research institutes like the 
Stanford University, the Massachusetts Institute of Technology and the Carnegie-Mellon 
University. One of the first prototypes was DENDRAL, an expert system designed to solve 
problems in mass spectrometry (15). The frrst system in the field of medici.,"le was MYCIN, 
designed at Stanford University for the diagnosis and therapy of infectious disorders (16). 
An expert system is characterized by separation of the expert knowledge from the 
surrounding program. When this was done with MYCIN, the surrounding program 
remained as an empty shell and was called EMYCIN (Essential or Empty MYCIN). This part 
of MYCIN can be used to build expert systems in other fields of knowledge. 
The early large expert systems like INTERNIST-! were run on mainframes (17). Nowadays 
there is a trend towards smaller computers: workstations, personal computers and even 
an occasional pocket calculator. 
A wide scale in magnitude of lrn.owledge domains may be found: large systems like 
INTERNIST-I (internal medicine, ref.l7), systems of intermediate size li.l<.e HEPAR (hepato-
logy, ref.IS), smaller systems like BCDE2 (microcytic anemia; ch.6) and systems with a 
very small domain like erythrocyte enzymes or isoenzymes of cholinesterase (section 1.9). 
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1.6.3 Languages arul shells 
Many computer languages have been used to develop expert systems; the eldest are USP 
(List Processing Language) and PROLOG (Programming Logic). A great variety of llSP 
dialects exists. The major part of this thesis deals with expert systems in a llSP 
environment. 
Numerous empty shells have been developed, of which a few examples are given: 
EMYCIN (usP, Stanford University), Personal Consultant Plus (LISP, Texas Instruments), 
EXPERT (FORTRAN, Rutgers University, ref.l9), SMR (Israel Institute of Technology, 
ref.20), KEE (USP, Intellicorp), Acquaint (LISP, LithP Systems), DELFI (TurboPascal, Delft 
University of Technology, ref.21), Goldworks (LISP, Bolesian Systems Europe), Pro.M.D. 
(PROLOG, ref.22), Nexpert Object (C) etc. These shells were developed to enable the 
building of expert systems without lmowledge of high level computer languages like llSP 
or PROLOG. 
I. 6.4 Structure 
Traditionally, an expert system consists of a part containing the expert lmowledge (the 
!mow ledge base) and a part driving the process of reasoning (the inference engine). The 
knowledge is represented in rules with a PREMISE and an ACTION part similar to IF .. TIIEN 
structures. The process of reasoning can be either data driven, goal driv~ or a 
combination of both. In the first case new facts are deduced from input data (forward 
chaining). In the second case possible conclusions are verified by retrieval of data leading 
to acceptation or rejection (backward chaining). A combination of both mechanisms is 
a more powerful approach and more resemblant to human problem solving. 
The rules in an expert system are grouped into contexts, which are rulegroups that 
functionally belong together in dealing with a specific part of the problem. This structure 
is helpful in keeping an overview when the expert system development becomes 
complicated. Ru]es are used to conclude facts, to evoke programs (internally in llSP, or 
externally in e.g. PASCAL, FORTRAN, or C), or to guide the inference process. The latter 
rules are called meta-rules because they contain lmowledge about the other rules, and thus 
represent a higher level of 'intelligence·. They can be used for example to compel the 
system to 'change its mind' about what part of the lmowledge has to be consllited, or to 
"forget' some tasks it had planned to do, in cases where these are no longer relevant. 
In the newer shells, more emphasis has been laid on an effective communication with 
databases. Thus, a situation of complete automation can be created where the time-
inefficient question-and-answer interplay with the user is avoided and data can be 
retrieved from a database, which is also less prone to human error. In the reverse 
situation, conclusions made by an expert system may be stored in the database. 
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1.6.5 Function 
The definition of an expert system mentioned above is divided between two functions: 
one of expert judgement and one of expert teaching. In our opinion these functions should 
not be combined in the same system, since the expert system as a tutor carries a large 
amount of ovenveight which is not needed in a consultancy situation. 
The ability of expert systems to explain their line of reasoning is largely overestimated. 
Generally, the user may ask, by means of keyboard input, why the system requires 
additional data, or how the system anived at the current intermediate conclusion. The 
system may reply that the data was needed in order to trace the value of a certain 
parameter or alternatively, that it reached its conclusion by applying the action part of the 
current rule (which is then given). Of course this is far from a situation of teaching the 
art to a novice. In our opinion, systems for tutorial situations need to be developed 
separately, because the kind of knowledge needed for tutorial and explanatory situations 
is different from that of giving expert judgement. For completeness, it must be mentioned 
that these explanatory functions can be quite useful in the development phase of an expert 
system. 
Expert systems can be used in several ways. One is a function as a 'watchdog • to select 
the cases that deserve the detailed attention of a human expert. Here, the bulk of 
relatively simple cases are treated without human intervention and the system largely acts 
as a time-saver for the real expert. Such systems have a rather broad but shallow 
lmowledge base. 
Another function is that of an expert only for complicated cases. These systems typically 
have a large lmowledge base limited to a small area of expertise. In this case the 
conclusions generated by such a system shonld be accepted only after being reviewed by 
a human expert. Usually, this expert will not be impressed by the advice of his binary 
colleague because he would have given the same advice. There may arise differences of 
opinion between the prognnn and the expert if the latter was not involved in the 
development of the system. Disagreement between human experts has been documented 
repeatedly (23-25). Especially for this type of expert system the development phase never 
ends because it has to be continuously refmed according to the state of the art. 
1.7 Problems in developing expert systems 
Several difficulties may arise in the development of an expert system. Depending on the 
domain of lmowledge, the choice of the appropriate hard- and software is a major issue. 
We experienced that in the long run the 640 kb internal memory of our Olivetti M24 SP 
personal computer became a !imitation for the developing prognnn. A survey of the 
literature shows that the larger systems have all been built on mainframes or workstations. 
On the other hand, it has always been stressed that the choice of too large a lmowledge 
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domain should be avoided. Indeed, many systems have been developed on personal 
computers in conventional programming languages. 
Another problem is the collection of information from different locations (apparatus) that 
is not produced simultaneously. For simple sirnations this may be done by human 
intervention. Alternatively, information may be obtained from the hospital information 
system or from a laboratory database. Apart from this timing problem, the sirnation 
becomes more complex when clinical information is to be part of the input data. 
Although age, sex, and in some cases medication may be obtained from the hospital 
information system, simple data like length, weight or body temperature will dictate 
human intervention, and thereby inefficiency. Such data can only be obtained through 
co-operation of non-laboratory staff. We therefore advocate the development of systems 
that are lintited to laboratory matters. These could well make use of an (internal) working 
hypothesis but they should never attempt to make a clinical diagnosis because the 
necessary information is lacking. We expect that this approach will prove helpful in 
attaining acceptance for these systems. 
Before an analysis of the lmowledge domain is made, it has to be decided whether the 
expert and the knowledge engineer will work as a team or whether the expert is to 
implement the knowledge himself. Some groups have developed special interviewing 
techniques because it was difficult for the experts to explain all details of their reasoning. 
In the development of LrTIIOS ( ch. 2), we have found it rewarding to take a short course 
in expert system development and do the job ourselves, working in a team of two 
persons. 
Another well-lmown problem in expert system development concerns the performance at 
the border of the knowledge domain, i.e. can the system decide whether the problem is 
(partially) beyond its capability. Although this is not likely to present a real problem in 
clinical chemistry, this difficulty can be dealt with by meta-rules. Furthermore, it is 
important to keep in mind that the transfer of expert systems between hospitals is not 
always possible. Another 'school' of decision making, or other analytical methods may 
be present and systems that depend on population studies may show failure. 
1.8 Legislation 
Using an expert system that has to contribute information for clinical decisions means 
dealing with the question of responsibility. Who is to be held responsible if the system 
contributes with faulty information that could result in a decision that ultimately proves 
fatal to the patient? ls it the over-confident expert who provided the knowledge to be 
incorporated in the program; is it the knowledge engineer who failed to detect that the 
program was not flawless; or is it the user of the program, be it a clinical biochemist or 
a physician, who omitted to convince himself of the impeccability of the system? The 
answer to these questions depends on the sening in which it occurs. Although literature 
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about this subject is rather scarce, some considerations about the German situation have 
been published by Hoffmann (26). It seems logical to accept that the responsibility should 
lie with those who apply such systems to provide information for the clinic. The situation 
can be compared to the purchase of a newly developed analytical instrument, for which 
flawless behaviour is claimed by the manufacturer. The buyer should convince himself 
of the reliability of such an instrument when it is used in daily routine. In the same way 
that he is responsible for the analytical quality of its results, he should also stand for the 
quality of the information that is provided by expert systems. 
1.9 Applications in clinical chemistry 
An overview of applications is given in Table 1.1. 
Table 1.1 Overview of interpretative systems for clinical chemistry. 
Subject 
Acid-base disorders 
Electrolyte disorders 
Anemia 
Myelodysplastic syndromes 
Leukemia 
Erythrocyte enzymes 
Transfusion reactions 
Red-cell antibody identification 
Platelet request evaluation 
Bleeding disorders 
Complement factors 
Calcium metabolism 
Calcium/phosphorus metabolism 
Alkaline phosphatase isoenzyme patterns 
Cholinesterase isoenzyme patterns 
Hepatic enzymes 
Serum and CSF protein electrophoresis 
Aspartate aminotransferase elevations 
Urinalysis 
Lipoprotein disorders 
Thyroid disorders 
Renal stone analysis 
Instrument troubleshooting 
Validation of analytical results 
Literature reference 
See chapter 4, Table 4.4 
27,28 
See chapter 6, Table 6.9 
29 
30,31 
32 
33 
34 
35,36 
37 
38 
39,40 
41 
42 
43 
44 
45-47 
48 
49 
14,50-52 
53,54 
55-58 
59,60 
61 
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l.HI Future developments 
The areas where expert systems may fmd a fruitful application begin to delineate. There 
have been encouraging developments in the troubleshooting of analyzers (59,60). Another 
field of interest is accelerated laboratory investigation (62,63). Following this approach, 
analyzers may be equipped with expert systems that generate the next logical test from 
the current test results. When fiatted by the physician, this next test may be carried out 
using the same sample. This saves time of both physician and patient, it is less 
discomforting to the patient because only one rather than two samples are needed, and 
it enables a systematic approach in the diagnostic work-up. 
In the future, expert systems coupled to the hospital information system may retrieve 
information about the medication and decide if an aberrant test result was caused by drug 
interference. Large databases in this field are commercially available nowadays. This 
application is in fact part of the plausibility control, which could become another field of 
application for exPert systems. At the same time, information could be generated by multi-
variate analysis of suitable combinations of parameters (ch. 5). The same technique could 
be used to determine which tests should be rerun because of questionable plausibility. 
In our view, the incorporation of the time factor could become rewarding as well. In this 
way, a dynamic instead of quasi-static control of a patient is possible. This approach calls 
for rapid retrieval of historical information, either from a laboratory database or from the 
hospital information system. 
l.U Scope 
The object of this thesis is to explore how expert systems may be helpful in information 
enhancement for clinical chemistry. Several prototypes have been built in order to 
investigate the advantages and disadvantages. A discussion of existing and new ideas with 
ample references has been added to create a birds eye view of the area, and to allow the 
interested reader a deeper dive into the subject. lt is hoped that this thesis will act as a 
catalyst in reverting the existing scepticism into enthousiasm. 
Chapter 2 is a description of LITHOS, an expert system for X-ray diffraction analysis of 
urinary calculi. A comparison of this system with CALCULI, a conventional computer 
program for the same purpose is given in chapter 3. Chapter 4 contains a discussion of 
acid-base nomenclature and a short description of CHEMPATII, an expert system for the 
diagnosis of acid-base and electrolyte disorders. In chapter 5, examples and a discussion 
are presented of multivariate analysis as a tool in clinical chemistry. Some explorations 
in developing an expert system for the laboratory diagnosis of anemia (HEMO) are 
discussed in chapter 6. Chapter 7 presents a general discussion of the application of 
expert systems in clinical chemistry, as well as the experiences with the various systems. 
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Chapter 2 
LITH OS 
AN EXPERT SYSTEM FOR THE INTERPRETATION OF 
X-RAY DIFFRACTOGRAM DATA 
2.1 Introduction 
Urinary calculi are found with a prevalence of approximately 4.7% in the Dutch 
population (1). The analysis of urinary stones provides the attending physician with data 
to install an appropriate treatment. The analysis of utinary stones is usually done by 
X-ray diffraction with a Debije-Scherrer-Hull camera. X-ray analysis and infrared 
spectroscopy are superior to chemical analysis, which is known to be hampered by a large 
fraction of false positive (mistakenly detected) and false negative (mistakenly missed) 
components (2). An extensive description of X-ray diffraction is beyond the scope of this 
thesis: the interested reader is referred to the publication of Dosch et aL (3). 
An analysis with the Debije-Scherrer-Hull camera results in a pattern of several 
concentric dark rings on a photographic fllm (4). The radius of these rings is a measure 
of the crystal lattice distances, whereas the photographic density indicates the intensity 
of the reflected radiation, which is a measure of concentration. The interpretation of this 
pattern is done by specialists with many years of experience and yields the composition 
of the calculus, qualitatively as well as semi-quantitatively (mass percentages). 
Treatment of patients with renal calculi is now routinely done by means of extracorporal 
shock wave lithotrypsy. This non-invasive technique has resulted in a considerable in-
crease in requests for diffraction analysis (5). The ensueing need for a greater analytical 
capacity was satisfied by means of a diffractometer analyzer. The digitalized output from 
this instrument is transferred to a personal computer to be interpreted by an expert 
system. 
2.2 Sample preparation 
As a first step in the analysis of renal stone components, the complete calculus is ground 
in an agath mortar. The grinding should be carried on long enough to ensure that the 
particle size is sufficiently small. The monocrystalline silicon applicator disk is rubbed 
with Apiezon L grease (E. Merck, Darmstadt, Germany). The excess Apiezon is skinuned 
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off with a microscopic object glass. At least 4 mg of the powder is distributed on the 
disk. It is then gently tapped with its side on the mortar to remove the excess powder. 
This procedure results in a regularly distributed layer of the sample. 
2.3 The diffractometer system 
Analyses of urinary calculi are performed using a Compact X-ray Diffraction Analyzer 
System (PW 1840/10; Philips Nederland BV, Eindhoven, The Netherlands). This system 
consists of a high voltage generator (PW 1729), an X-ray tube with a copper anode, a 
goniometer driven by a stepping motor, a nickle filter, an X-ray detector, and a control 
unit. The latter is equipped with an integrator/interface board which permits remote 
control by means of a personal computer. The X-ray tube is operated at 40 kV/50 rnA 
and emits Ka12 radiation of 1.542 A, and K~ radiation of 1.392 A. The diffractometer 
output consists of diffraction angles (in steps of 0.01 o through a range of 9.00-47.00°) 
and the corresponding intensities. The scan speed is a compromise between optimal peak 
resolution and miuimal analysis time and is set to 0.05°/sec. The time constant (T) of the 
apparatus is set to 0.5 sec. With these settings the intense peak of a-quartz at 26.72° is 
measured at 92% of its true value (T/<J ~ 0.2, where <J is the standard deviation of the 
peak). 
The diffraction angles (20 values, ref. 3) and intensities of the reflection are sent to an 
Olivetti M24 Personal Computer, equipped with a 20 Mb Winchester drive and a 5.25 
inch floppy drive. The personal computer has an extended internal memory of 640 kb and 
an Intel 8087 coprocessor unit. 
2.4 The diffractometer control program 
A small demonstration program in GW BASIC for remote controlled operation was supplied 
by the manufacturer. The program was rewritten in TURBO BASIC and extended to enable 
data manipulation. The following features were added: storage of the raw data from the 
diffractometer, Savitzky-Golay 11-point ftltering, noise threshold generation, curved 
baseline subtraction, calculation of the frrst derivative, peak selection, screen presentation, 
and storage of selected data in a format suitable to be used by the expert system. 
In order to calculate the quantitative composition of the sample, the expert system UTIIOS 
uses peak heights rather than peak surfaces. The integration of peaks in this automated 
setting is a nearly impossible task because of the many overlapping, irregularly shaped 
peaks, ahd the interference of small peaks from the sample matrix. As an illustration, 
figure 2.1 shows a typical dllfractogram of Apatite, a component that is known for its 
microcrystalline structure and therefore its lack of sharp, well defmed peaks. 
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One of the tasks of the control program is to obtain the peaks that are relevant to sample 
identification. In general, only two or three peaks are needed for each component. Any 
larger number of peaks results in an unnecessary long consultation time of LTIHOS. 
During a scan, data are sent from the diffractometer to the personal computer in floating 
point numbers. In order to reduce the influence of noise signals, an 11-point Savitzky-
Golay filter is applied to the ID.tensities and the resulting diffractogram is presented on 
the screen. This filter is a weighed smoothing procedure calculating each peak height 
from 11 terms. The filtered intensities and the scan parameters are saved on the hard disk. 
If dnring a scan, a transmitted value surpasses a defanlt maximum intensity, the 
diffractometer is instructed to restart the scanning procedure with half of the current 
detector sensitivity. Conversely, if the maximum intensity is too low, the scan is repeated 
with twice the current sensitivity. 
Following the noise filtering, a baseline subtraction is performed. The baseline is a curved 
ascending line over the whole scanned range and results largely from background 
reflection from the silicon application disk, and a small 'aspecific' contribution from the 
sample. Numerical analysis of the baseline in a variety of diffractograrns by means of the 
program CFIT (J.C. Hudson, 4198 Warber Dr., Flint, Michigan 48504, U.S.A.) yielded five 
'best fit' equations, e.g.: In[intensity] ~ c1 + c:J[20]. In this equation, c1 and c2 are 
0.32 
0.24 
$ 
·u; 0.16 c: 
Q) 
c 
0.08 
0.00 
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Reflection angle (degrees 2 8) 
Figure 2.1 Diffractogram of Apatite (Ca10(POJ 6(0H)z)from a renal calculus. 
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constants that are estimated through least -square regression. Using this equation, the 
correlation coefficient of the fit to a diffractogram is typically between 0.78 and 0.86, 
compared with 0.69-0.76 for the fit with a straight line. The program determines the 
correlation coefficient for each equation and uses the one with the highest correlation for 
baseline subtraction. 
After the baseline subtraction, the frrst derivative spectrum is calculated to determine the 
exact peak top positions. To reduce the effect of the noise which is caused by taking the 
derivative, the frrst derivative is calculated from intensities lying two steps·(0.02°) instead 
of one step apart. From the frrst 250 values of this frrst derivative spectrum the standard 
deviation of the noise in this signal is calculated. In this range of the diffractogram, no 
peaks are encountered. 
A peak entry is signalled if, in the frrst derivative, an intensity greater than twice the 
standard deviation of this noise is encountered, followed by five sequential values in 
ascending order. The position of the peak top is selected, if there are two adjacent non-
negative values of the fi.rst derivative, followed by one negative value. 
2.5 The expert system shell 
For the implementation of LITIIOS, the Personal Consultant™ expert system shell, version 
1.10 Ganuary 1985) from Texas Instruments Inc., Austin, Texas, U.S.A. was used. 
Additional use was made ofiQ LISPTM version 1.7 (november 1984), from Integral Quality 
Inc., U.S.A. 
In expert systems, the driving force of the reasoning process can be either data or 
conclusions. In the former case, the system tries to deduce new facts from the data it has 
been given (data driven reasoning or forward chaining). In the latter case the system tries 
to verify conclusions (goal driven reasoning or backward chaining). A combination of 
these types of reasoning is also possible and generally leads to more powerful reasoning 
processes. UTHOS however, is based on backward chaining reasoning. 
The empty shell used for LITIIOS is built in LISP (List Prograrmning Language) and may 
be manipulated by user-made additional LISP programs. Because the Personal Consultant 
shell was the frrst commercially available version, it lacked several features which 
were later included in the Personal Consultant Plus shell, which is a more advanced 
version of its predecessor. We developed these features in the form of additional LISP 
programs. 
2.6 Source of the knowledge 
The lmowledge incorporated in the expert system LITHOS has been partly obtained from 
an expert (diffraction patterns), partly from experiments (determination of sensitivity 
factors), and partly from the literature (calculation of mass percentages). The expert had 
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16 years of experience in diffraction analysis with the Debije-Scherrer-Hull camera and 
had been trained at the Faculty of Physics at the Technical University Delft, The 
Netherlands. X-ray diffraction analysis has been shown to perform well in both Dutch and 
German surveys (2). 
2. 7 The structure of the expert system 
The knowledge base of the expert system consists of parameters, domain variables, 
dynamic property lists, functions, and rules. The entire system occupies approximately 
315 kB of disk space. The 90 parameters are used to store information, to direct the 
inference process, and to drive the consultation. The 19 domain variables are used to store 
constants, such as 2€> values, margins of between-run variability of 2€> values, 
combinations of components that have overlapping peaks, and sensitivity coefficients 
relative to magnesium oxide. Property lists are generated dnring the consultation and 
serve to store temporary information that has to be manipulated, such as lists of 2€> values 
and intensities, and a list of primarily matched components. The 26 LISP functions are 
used for a variety of purposes such as calculations, alterations in property lists, matching 
of 2€> values, alterations of meta-rules (see below), production of the screen layout, 
storage of the result on disk. 
The 102 rules are used to determine the value of parameters, to invoke LISP functions, 
and also to gnide the inference process. The latter type of rules, called meta-rules, decide 
which rules are to be used in the present consultation and are constructed by correspond-
ing LISP functions dnring each consultation. The rules of LITHOS are organized in 15 
groups, eacb containing rules that functionally belong together. These rulegroups are 
called contexts. There is one parent context dealing with general tasks such as input, 
output and the selection of a list of primarily selected stone components. All other 
rulegroups are subcontexts of the parent context, and are designed to handle problems 
arising from the presence of two or more components having the same or overlapping 
reflection angles. One subcontext is designed to signal the presence of possible artifacts 
or the presence of components that are unknown to the system. 
2.8 Consultation 
The sequence of events in a consultation will be described in this section. For the 
interested reader, an extensive example is available from the author of this thesis. As 
mentioned above, the control program has been designed for communication with the 
diffractometer and for preprocessing of the raw scan data. The sequence of events is fully 
automated once the scan is started and can be summarized as follows: 
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L Scanning 
2. Storage of raw data 
3. Noise filtering 
4. Baseline subtraction 
5. First derivative calculation 
6. Calculation of the standard deviation of the frrst derivative 
7. Peak selection 
8. Storage of reduced data 
The raw data from the scan are stored in order to create the possibility of repeating a 
consultation to study the influence of slight modifications in the control program. 
The next step is the consultation with L!TilOS, which is initiated by the human operator. 
The whole sequence is summarized below: 
L Retrieval of reduced data 
2. Test for amorphous material 
3. Primary selection of components 
4. Sorting of components in order of decreasing dominance 
5. Administration of recognized peak positions 
6. Conversion of matched peak positions to default values 
7. Detection and removal of artifacts 
8. Correction of intensities for interference of other components 
and removal if necessary 
9. Single component check 
10. Calculation of quantitative composition 
11. Administration of unmatched peaks 
12. Unknown component check 
13. Output of an analysis report 
When the peak positions and corresponding heights have been retrieved from disk, LTIHOS 
frrst checks whether more than 100 peaks have been found, in which case the sample is 
designated as amorphous material and the consultation is discontinued. 
If this check is passed, a primary selection of components is made. In its database L!TilOS 
contains two and sometimes three characteristic peak positions for each of 18 possible 
components. LITHOS compares these positions to the measured values for component 
recognition. For several reasons, the measured peak positions may differ slightly from the 
stored values and may thus fail to be recognized. To overcome this difficulty, every 
stored characteristic value has its specific margin within which the measured value is 
allowed to vary in order to still be recognized. 
The next step is the sorting of the selected components in order of dominance, which is 
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defmed as the product of the intensity of the first matched peak and the sensitivity factor 
for the component. This factor is a measure of the inverse reflection intensity and has 
been determined relative to magnesium oxide by the internal standard method of 
Rebentisch et aL (6). Later in the consultation, urnos will verify which components are 
truly present, beginning with the least dominant ones. The components that are not 
present are removed from the list and the remaining components are evaluated for 
coinciding peaks. The early removal of improbable components greatly reduces the 
number of coincidences that has to be checked. 
After the sorting process, the measured diffraction angles of the components that have 
been found are compared with corresponding default values of those components. This 
list is analogous to the one previously mentioned but contains more peak positions and 
margins. The default values that have been matched and the corresponding intensities are 
stored in a separate list. Note that the default values and not the measured values are 
stored. This facilitates later retrieval procedures because the default values are invariant 
from run to run. The two stage process described above (selection - extensive matching) 
is time saving because only the selected components are compared rather than the whole 
list of primarily matched components. 
The sorted list of components is now used to select the subcontexts of urnos that deal 
with the selected components, starting with the least dominant one. Usually the presence 
of these components is mimicked by minor peaks of other components which happen to 
coincide with the two peaks needed for recognition. As an example of a step in the clean-
up procedure, the component sodium chloride will be removed if: 
1. Apatite, Whitlockite, or ammonium urate is present, and 
2. The intensity of the largest peak (sodium chloride) is less than 15000, and 
3. The position of this component in the sorted list is third or greater. 
As has been mentioned before, the removal of such "false positive' components reduces 
the number of rules dealing with coincident peaks that has to be consulted. 
The selection of the part of the knowledge that has to be consulted is done by a USP 
function which alters the premise of one of the rules in such a manner that the inference 
process is guided to those rules that are relevant to the actual consultation. In this way, 
the content of this so-called meta-rule will be altered in each consultation. The rules 
dealing with components that have not been found in the sample will not be consulted and 
can be regarded as temporarily 'forgotten'. The option of meta-rules has been incorporated 
by the manufacturer in the empty shell of a newer version: the Personal Consultant Plus. 
The meta-rule steers the consultation along those rules that investigate the possible 
coincidences among components. Its premise is created from the sorted list of components 
in such a way tltat the least probable components are dealt with first. Successively, each 
part of this premise invokes the system to enter a subcontext dealing with one component 
from the sorted list. In this subcontext, a component can be removed if necessary, in a 
way analogous to the example of sodium chloride. For each component, LITHOS keeps a 
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list of all components that are known to cause coincidences with the component under 
consideration. This list is used to select the interfering components that are actually 
present. With this list a secondary meta-rule is constructed which again guides the system 
along all the coincidences with the component. Suppose the component ammonium urate 
has been detected because of coincidence of a Whewellite peak with its major peak. Then 
this peak can be corrected for the presence of Whewellite if a second Whewellite peak 
as well as the intensity ratio of both peaks in pure Whewe!lite are known. After the 
correction procedure, the component is removed from the list if the remaining intensity 
is below a certain lllnit. In this case it will be useless to correct other components for 
coincidence with the component that has just been removed. To avoid these fruitless 
efforts all other preplanned actions concerning the removed component are cancelled at 
the time of its removal. It is possible however, that the corrected intensity is above the 
removal limit. If this is the case, the component is not removed and the corrected 
intensity is kept by the system for further use. ln this way, an intensity may be corrected 
more than once because of multiple interferences. 
The next step is a check for a single component. The calculation of mass percentages is 
bypassed if, after all corrections, the sorted list contains only one component; the mass 
percentage of this component is then set to 100%. If there are more components, the 
relative composition ill mass percentages is calculated according to Rebentisch (6). 
At the end of the consultation, a list of measured peak positions that have not been 
recognized by the system is constructed. If there are many unrecognized positions, the 
presence of an unknown component may be suspected. This list is obtained by subtraction 
of all peaks associated with the diagnosed components from all the measured peaks in 
this sample. The former are recruted from a large list containing all peak positions that 
have ever been measured for each pure component (4-36 positions for each component). 
Finally, a screen report is generated presenting the qualitative and quantitative 
composition of the sample, possible warnings for artifacts like quartz, gypsum, or the 
presence of an unknown component. 
Typical consultation times are between 30 and 60 seconds for a multiple stone, whereas 
stones with ouly one component can be analyzed within 10 seconds. ln a typical example 
of a stone containing two components and a primary selection of five components, LITH OS 
used ouly 25% of its rules. 
2.9 C ondusion 
The project of developing LITI!OS has taken approximately 2 years and yielded an expert 
system that is used in routine practice (7). Nevertheless, it should be remarked that 
LITHOS is not meant to function entirely without human expert supervision. In case of 
doubt (e.g. rare components, artifacts, or more than four components), the analysis is 
repeated with a newly powdered sample. ln rare cases, an X-ray film is prepared with the 
24 
Debije-Scherrer camera in order to provide a decisive oprmon. The Debije-Scherrer 
technique is also used for sample sizes smaller than 4 mg. 
In this way we have created a situation in which the bulk of the daily routine can be dealt 
with by relatively inexperienced workers in the absence of a human expert. The system 
saves time because fewer films have to be developed and dried (14 and 10 min., 
respectively). The sample preparation time, the scan time, and the interpretation time are 
essentially the same for both methods (3, 14 and 2 min., respectively). 
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Chapter 3 
LITHOS AND CALCULI 
TWO COMPUTER PROGRAMS FOR THE EVALUATION OF 
X-RAY DIFFRACTOGRAMS OF URINARY CALCULI 
3.1 Introduction 
The prevalence of urinary calculi in the Dutch population is approximately 4.7% (!). 
With the introduction of an extracorporal shock wave lithotryptor in our hospital, the 
clinical chemistry laboratory has been confronted with a massive increase in requests for 
renal stone analysis. Traditionally, this analysis was done by X-ray diffraction with a 
Debije-Scherrer-Hull camera and the darkening patterns were interpreted by a specialist 
with many years of experience. In order to expand our capacity, a diffractometer was 
purchased. This instrument is equipped with an X -ray detector and it is able to com-
municate its output (diffraction angles and reflection intensities) to a personal computer. 
At the same time, an expert system shell for use on personal computers became commer-
cially available, and we undertook the development of an expert system for interpretation 
of X-ray diffraction data (2). At the Faculty of Physics of the Technical University Delft 
and the TNO Institute of Applied Physics, Delft, The Netherlands, a Pascal program was 
being developed for the interpretation of digitized X-ray patterns from a Guinier-
Johansson camera, of crystalline samples. A co-operation was started and the program 
was modified to be used in the hospital setting. 
The two programs represent t\Vo different approaches to the same problem: one by means 
of a rule-based expert system, and one by means of a Pascal program which makes use 
of multivariate calibration. This prompted us to make a limited comparison of the 
performance of both systems. 
3.2 Materials and methods 
All mineralogical components used for calibration, method comparison, and reproducibil-
ity experiments were of human source. This was done because large differences in 
diffraction properties are lmown to exist between components from commercial and from 
human source (3). For the details of the sample preparation, diffractometer system, and 
diffractometer control program, the reader is referred to chapter 2, section 2.2 to 2.4. 
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3.2.1 UTHOS 
urnos is an expert system for the interpretation of X-ray diliractograms of urinary 
calculi. The program has been described elsewhere (2). lt is a rule-based, backward 
chaining expert system developed to calculate the qualitative and semiquantitative 
composition from X -ray diliractograms of nrinary calculi. Further details can be found 
in chapter 2. 
3.2.2 CALCUU 
CALCUU 4.0 is a computer program for the evaluation of X-ray diffractograms of urinary 
calculi. It was developed at the department of Crystallography (Faculty of Technical 
Physics) of the Technical University Delft, The Netherlands. The program is written in 
Turbo Pascal 3.0 and is run on an Olivetti M24 Personal Computer equipped with a 8087 
coprocessor unit. CALCUU occupies 108 kB of disk space. The program calculates the 
qualitative and semiquantitative composition from X-ray diffractograms of urinary calculi. 
CALCUU uses mass absorption coefficients from the literature for the calculation of the 
semiquantitative composition. 
ln order to calculate the qualitative composition, the program compares the peak positions 
of the pure components within a margin of 0.1 o with the measured peak positions (the 
diliractogram is registrated in steps of O.QJ 0 ). The peak positions (8-29 for each 
component) and heights have been experimentally determined for each pure component 
and are contained in the program. Components are taken into account if more than two 
peaks have been recognized in the diffractogram. 
ln the calculation of the mass fractions of each component, peak heights are used to 
estimate the mass fraction of each component. An important difference with the approach 
of urnos is that, instead of ouly one peak, 8 to 29 peaks for each component are used 
to calculate the corresponding mass fraction. This amounts to a total of approximately 
300 peak positions. The measured height at each of these 300 peak positions in the 
diffractogram is modelled as a linear combination of heights of the pure components that 
are present. The crucial point is to determine the coefficients by which the peak heights 
of the pure components have to be multiplied in the linear equation. This is achieved by 
the least squares method, where the sum of all squared differences between measured and 
predicted heights is minimized by varying the coefficients. When the quadratic error has 
been minimized, the corresponding set of coefficients is used together with the mass 
absorption coefficients to calculate the relative mass concentrations of all components. 
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3.3 Results 
3.3.1 Method comparison 
In order to investigate the merits of the respective computer programs. a comparison was 
made with the results of the Debije-Scherrer method (Table 3.1). For a number of renal 
calculi, the relative content of one component as found by LTI110S or CALCULI was 
compared with the content found by the Debije-Scherrer method. 
Table 3.1 Regression of LITHOS (method 1) or CALCUli (method 2) on the Debije-Scherrer method. 
The number of observations N, correlation coefficient R. slope, intercept, and the standard deviation 
of the residual error of regression Syx are presented. 
Component Method N R Slope Intercept s"' (%) (%) 
Whewellite 1 150 0.98 0.97' 3b 5 
2 40 0.97 0.96 4 6 
Weddelite 1 93 0.98 0.97a 2b 4 
2 31 0.91 0.73' 2 8 
Apatite 1 142 0.95 0.98 1 6 
2 33 0.84 0.86 8b 10 
Struvite 1 56 0.97 1.00 -1 5 
2 5 0.99 1.15 -5 3 
Brushite 1 35 0.97 1.00 0 5 
Uric acid 1 26 0.98 1.04 -4 4 
Uric acid dihydrate 1 10 0.99 LOS 0 3 
Ammonium hydrogen urate 1 5 0.87 0.94 5 10 
Whitlockite 1 9 0.93 1.09 -9 8 
Cystine 1 5 1.00 0.93 7 1 
asignificantly different from 1 (Student t test; p <0.05) 
bSignificantly different from 0 (Student t test; p <0.05). 
3.3.2 Reproducibility 
In order to investigate the reproducibility of the analytical method in combination with 
both computer programs we measured material from one renal stone fifteen times. The 
means and standard deviations are shown in Table 3.2. Standard deviations were not 
significantly different between LITHOS and CALCUU (Fisher's exact test; p <0.05). 
In several further experiments we tried to quantify the contribution to the total variation 
of the effects of different steps in the sample preparation. 
Experiment a. Five times a mixture of 40% Whewellite, 40% Wedde!ite, and 20% Apatite 
was prepared, powdered, and a diffractogram was taken. This experiment was designed 
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Table 3.2 Reproducibility example of LITHOS (method 1) 
and CALCULI (method 2). Fifteen measurements of the 
same human calculus. For explanation see text. 
Component Method Mean(%) Stand. dev.(%) 
'\VheweHite I 44 . 6.4 
2 39 4.5 
Weddelite I 42 4.9 
2 36 3.0 
Apatite I 14 6.0 
2 24 5.9 
to measure the combined effects of powdering and application. The variability introduced 
by weighing is negligible.· 
Experiment b. A mixture was made of the above composition, powdered. With this 
mixture, five diffractograms were produced, i.e. powder of exactly the same composition 
was applied five times to the silicon disk and analyzed. This was done to measure the 
effect of sample application. 
Experiment c. A mixture of the same composition was applied once to the silicon disk 
and five spectra were taken with removal and replacement of the disk between the runs. 
This was done to estimate the influence of possible disturbance of the powder layer. 
Experiment d. Five spectra of the same mixnue were prepared without opening of the 
diffractometer between the runs. This was done to exclude variation that is due to sample 
handling. This experiment was repeated twice to confrrm the rather remarkable results. 
The results of these experiments with both systems are shown in Table 3.3. 
Next, two experiments were done to exclude effects induced by the diffractometer as a 
source of variation. In the first experiment we powdered a sample of quartz, applied and 
measured it in six successive runs without intermittent disk removal. The :intensity of the 
Table 3.3 Reproducibility experiments (40% Whewellite, 40% Weddelite, and 20% Apatite). 
a. Sample prepared, powdered and applied five times; b. Sample prepared and powdered once and 
applied five times; c. Five runs of a sample with intermittent disk removal; dl-d3. Five runs of a 
sample without intermittent disk removaL Method I: IJTHOS, Method 2: CALCUU. 
Component Method Mean(%) Stand.dev. (%) 
a b c d1 d2 d3 a b c dl d2 d3 
\Vhewellite I 38 45 37 38 42 37 2 2 I 2 2 3 
2 38 38 38 45 39 24 6 4 3 4 8 2 
Weddelite I 34 38 53 50 39 38 3 I 2 1 2 4 
2 34 32 36 39 36 40 6 3 2 4 8 3 
Apatite I 28 17 10 12 18 25 3 I 2 I 3 4 
2 28 31 26 16 25 36 10 6 4 8 15 4 
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major peak was measured and the variation coefficient was calculated to be 8.4%. In a 
control experiment we measured in the same manner a quartz sample that had been fixed 
to the silicon disk and was obtained from the manufacturer. The variation coefficient of 
the major peak was 0.9%. 
3.3.3 Unknown component 
In the evaluation phase of CALCULI it became apparent that the combination of 
Whewellite and the presence of an unknown component frequently occurred. Examination 
of the Whewellite base diffractogram showed a shift of 0.02-0.04° for all diffraction 
angles when compared with a newly measured diffractogram of pure Whewell.ite. The 
latter was installed as the new Whewellite base. To investigate the effect of this 
alteration, the diffractograms of 20 renal stones were selected which contained both 
Whewellite and the presumed unlmown compound. Ten of these were binary, five were 
ternary and another five were quaternary mixtures. The percentage of unknown 
component in these stones varied between 8 and 19%. After correction of the Wb.ewellite 
base, 18 stones were found to contain regular components only, whereas 2 stones 
remained that still contained the unknown compound. In both, the percentage of unknown 
component had shown a decrease to 7%. The quantitative compositions of 17 out of 20 
stones had come closer to those found by LITIIOS. 
3.3.4 Learning about ammonium hydrogen urate 
One of the components that are rarely found in renal stones in Western Europe is 
ammonium hydrogen urate. A visiting scientist from Indonesia, confronted us with the 
problem of calculating ammonium hydrogen urate. He brought a large number of renal 
stones that almost invariantly contained ammonium hydrogen urate. This enabled us to 
teach the expert system to recognize the new component. Table 3.4 shows the results of 
LITI!OS and the Debije-Scherrer method. 
Table 3.4 Composition (%) of a calculus containing ammonium hydrogen urate. 
Debije-Scherrer 
Amm. hydr. urate 50 
Weddelite 40 
Whewellite 10 
10riginal consultation 
2 After modification. 
LITIIOS1 
Uric acid. 2H20 
Weddelite 
Whewellite 
Apatite 
Whitlockite 
LfTIIOS2 
2! Amm. hydr. urate 
4! Weddelite 
trace Whewellite 
28 Whitlockite 
10 
75 
25 
trace 
trace 
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3.3.5 Consultation time 
Although it is not an essential item, we have made a comparison of the consultation times 
with both systems (Table 3.5). Typical consultation times of 50 seconds are obtained with 
WhewellitefWeddelite/Apatite, which is a frequently occurring composition. UTHOS can 
do pure components within 10 seconds, but this is only a slight advantage compared to 
the sample preparation time (3 minutes) and the scan time (14 minutes). Occasional 
outliers in consultation time up to two minutes occur in both systems. Not included in 
Table 3.5 is the time needed for baseline subtraction and peak selection, which is 
approximately half a minute for both systems. 
Table 3.5 Consultation time (seconds). 
3.4 Discussion 
Qualitative composition 
Cystine 
Whewellite 
Apatite 
Whewellite{W eddelite 
Struvite/Apatite 
BrushitejWhitlockite 
Uric acid/Apatite 
WhewellitefW eddelite/ Apatite 
BrushitefWeddelite/Apatite 
WhitlockitefW eddelite/ Apatite 
3.4.1 Method comparison 
UTI! OS 
7 
9 
11 
48 
54 
54 
94 
52 
47 
54 
CALCULI 
30 
33 
30 
47 
45 
120 
70 
55 
55 
65 
The results obtained with UTHOS and CALCULI have been compared to those obtained 
with the Debije-Scherrer method, in which the X-ray flims are judged by a human expert 
(Table 3.1). Although this seems a rather subjective approach, it was the best alternative 
because X-ray diffraction analysis is regarded as being the golden standard and our in-
house experience had proven its virtues in previous external quality control programs. 
From Table 3.1 it can be concluded that both systems perform reasonably well. CALCULI 
has a relatively small slope for Apatite because it has the tendency to overdiagnose 
Apatite when present in smaller amounts. This effect tilts the regression line and thus 
gives a low slope. A secondary effect is caused by the frequent co-occurrence of Apatite 
and Weddelite. The overdiagnosing of Apatite results in underdiagnosing of Weddelite 
when it is present in large amounts. By analogy this gives a small slope. The reason for 
this lies in the microcrystalline structure of Apatite, which produces a very broad peak 
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of low intensity. When Apatite is present in small amounts it becomes difficult to 
distinguish the peak from the baseline noise. 
3.4.2 Precision 
In order to evaluate the precision of both methods, a stone of frequently occurring com-
position was taken and analyzed fifteen times. Table 3.2 shows standard deviations within 
7%. Standard deviations may of course vary with absolute composition. However, from 
the regression figures associated with Table 3.1 we can conclude that for the tlrree most 
frequently occurring compounds: Whewellite, Weddelite, and Apatite, only low amounts 
of Apatite will show large imprecision. Therefore, we chose to use the composition 
mentioned above, and to try and trace the major source of imprecision in this setting. 
A welllmown effect in X-ray diffraction analysis causing imprecision and inaccuracy is 
preferential orientation, which means that crystal planes are not exposed in a random 
fashion to the radiation. This causes some peaks in the diffractogram to become higher 
and others to become smaller than normal, which in tum leads to over- or under-
estimation of the mass concentration. In the Debije-Scherrer method the random 
orientation is provided by continuous rotation of the sample in the X-ray beam. However, 
in the method with a fixed silicon applicator this is not the case, so great care has to be 
taken to prevent preferential orientation. 
To dissociate the effects of the different steps in the sample preparation we devised the 
experiments shown in Table 3.3. Unfortunately, no large differences were observed 
between the steps of powdering, application, and disk removal. Perhaps the most striking 
effect is the :imprecision resulting from successive runs without opening the diffracto-
meter. When this experiment was repeated, similar results were obtained. For instance, 
the peak intensity ofWhewellite at 15.03° changed from 24478 to 19759 within five runs 
without opening the diffractometer, which is as much as 19% reduction. In a similar 
experiment with a fixed quartz sample we obtained a variation coefficient of 0.9% for the 
intensity of the highest peak, compared to 8.4% with a powdered quartz sample. This led 
us to conclude that the contribution of the diffractometer to the total variation is 
negligible. 
We can only speculate about the cause of the disturbing effect mentioned above, which 
hampers every attempt to improve the technique of the sample preparation. One 
possibility is the building up of static electricity in the instrument. This is known to 
concentrate at sharp points of conductors and might influence the orientation of the 
microparticles in the X -ray beam. 
3.4.3 Accuracy 
The evaluation of the accuracy in renal stone analysis by X-ray diffraction is a difficult 
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task. The technique of X-ray diffraction is regarded as the most reliable in this field. The 
accuracy of this method can not be evaluated by means of artificial samples prepared 
from commercially available components because these are lmown to have crystal 
structures that are different from their natural counterparts. Therefore, the accuracy of 
such methods can only be obtained by secondary means, e.g. round robin tests with 
mixtures of natnral components of maximal purity. 
The comparison of two programs judging the same diffraction data is an even more 
difficnlt task. Some idea can be obtained from the comparison with the Debije-Scherrer 
method (Table 3.1). The slopes for most of the components are satisfactorily, although 
CALCUU displays some overestimation of Apatite, especially in the lower percentages 
(figure 3.1). 
This compound presents a difficnlty because the diffractogram of pure Apatite is highly 
variable in shape (figure 3.2) and therefore only a grand mean can be used. 
The accuracy of UTHOS is diminished by the variation resnlting from preferential 
orientation. Because UTHOS relies for its calcnlation on only two peaks for each 
component, the phenomenon of preferential orientation is liable to exert considerable 
influence on the results. 
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Figure 3.1 Comparison of the results of UTHOS and CALCUU for Apatite. 
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Figure 3.2 Diffractograms of Apatite from: 1. A renal calculus (human), 2. Commercial source, 
and 3. A molar (human). 
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3.4.4 Additional comments 
The comparison of two computer programs for interpretation of the same set of data is 
of course a precarious undertaking, especially because there is no hard-core gold standard 
in this field. The results found by us represent a momentum in the ongoing development 
towards perfection. Both programs have their advantages and drawbacks. The use of an 
expert system shell has the advantage of enabling the inexperienced program developer 
to make a prototype in relatively little time, compared with the use of a conventional 
programming language. As has been shown above, the quality of the results these systems 
produce is in this case detei111.illed to a large extent by factors concerning the sample 
preparation. 
Therefore, in the daily routine, both programs are used side by side to judge each sample. 
If the results show a consensus, then they are taken to be correct and are transferred to 
the physician. If there is a disagreement, then the human expert examines the input dsta 
for preferential orientation. Often, a consensus is found when such a sample is 
redistributed on the disk and rerun. Results from external quality surveys over a period 
of two years ( 12 samples) have been qualitatively correct in all cases, quantitatively 
correct in 10 cases and deviating by 10% quantitatively in only two cases. 
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Chapter 4 
INTERPRETATION OF ACID-BASE MEASUREMENTS 
4.1 Terminology and interpretation of acid-base disorders 
The intetpretation of acid-base parameters should begin by a clear defmition of the 
terminology. The debate about this subject, now 25 years ago, has created two schools. 
These two schools hold different interpretations of the same terminology. which are 
liable to cause much confusion if defmitions and intetpretations have not been clearly 
defmed. ' 
The tenn 'acidosis' may serve as an example to explain this disparity. The frrst school, 
often said to use the 'laboratory intetpretation', applies this tenn to describe the chemical 
condition of blood at one point in time. This condition is defmed as a pH below the lower 
reference limit. It should be stressed that this is a static description and therefore cannot 
be used to decide by which process or processes this condition is reached. 
The other school, using the 'clinical' or 'physiological intetpretation', defmes acidosis as 
a process, leading to an accumulation of acid (or loss of base) in the body. This is a 
dynamic interpretation and therefore cannot be used to describe the actual measured value 
at one point in time. 
Nevertheless, the term 'acidosis' is used very often to describe the clinical condition of 
a patient based on a measurement at one point in time. Here, a new element is 
introduced, i.e. the fact that not only the acidity of the blood, but also other analytes are 
measured in the same sample. These are the carbon dioxide tension (PC02) and the 
bicarbonate concentration [HC03l in the blood. The measured value for both entities is 
the result of the rate of production and the rate of excretion from the body. All three 
variables are subject to an interdependency which is described by the Henderson-
Hasselbalch equation. 
[HCO ·1 
pH ~ pK' + Iocr 3 
"S xPC02 
In this equation, pK' is the negative logarithm (base 10) of the apparent equilibrium 
constant of the reaction between carbon dioxide and water to give a bicarbonate ion and 
a hydronium ion. The constant S relates the concentration of dissolved carbon dioxide to 
its partial pressure in equilibrium with the solution. 
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In order to make a correct acid-base diagnosis, knowledge is needed of the physiological 
regulation mechanisms such as the body's response to disturbances in the acid-base 
equilibrium, Le. the increase in bicarbonate production by the kidney, which is a slow 
process compared with the removal of carbon dioxide by the lungs, and the ventilatory 
response, which is dependent on the interstitial pH in the brainstem. 
The knowledge about physiological mechanisms has led to the use of the adjectives 
'metabolic· and 'respiratory·. Again, two different interpretations can be given of these 
tenns. 
According to the laboratory interpretation, a metabolic acidosis is regarded as a decreased 
concentration of the metabolic component in the blood. In contrast, the physiological 
interpretation of metabolic acidosis is a condition resulting from an accumulation of acid 
(other than C02) or from loss of bicarbonate. Once again, the laboratory interpretation 
describes the state of the blood, whereas the physiological interpretation describes the 
process. 
Two other qualifications that are often used in acid-base diagnosis are ~simple • and 
'mixed·. These are used to denote clinical conditions that result from one or from several 
etiological factors, respectively. Thus, a patient who has uncontrolled diabetes may have 
a metabolic acidosis with a ventilatory response and yet have a simple acid-base disorder. 
Would there be coexisting pulmonary insufficiency, then the condition would be denoted 
as a mixed acid-base disorder. It will be evident that these qualifications are not used in 
the laboratory interpretation. 
All disturbances of the acid-base equilibrium give rise to a compensatory response of the 
body in an attempt to tnaintain homeostasis. The degree of this compensation can be 
measured in two ways. In the laboratory interpretation, the compensation is said to be 
complete if the blood pH has been restored to normal. For the simple acid-base 
disturbances, the amonnt of compensation :in bicarbonate or carbon dioxide occurring 
normally is known and can be calculated with the corresponding confidence limits (1,2). 
The physiological interpretation denotes a compensation as being complete if the amount 
of response is within these confidence limits, regardless of the blood pH. 
It may be difficult, even :in simple disturbances, to recognize which is the primary process 
and which is the compensatory process. W'hen a patient with a metabolic acidosis is 
artificially ventilated, a ventilatory overcompensation may be the result, leading to a 
slightly elevated pH. Without knowledge of the clinical situation, one could be misled to 
conclude that a primary respiratory alkalosis was present, accompanied by a secondary 
and partial metabolic compensation. The same could occur with a patient taking 
medication which stimulates the respiratory center. Two examples will be given to further 
illustrate the complexity of the acid-base interpretation. 
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Case] 
A 70-year-old man who had been persistently vomiting over several days was admitted 
to the hospital with congestive heart failure (3). On examination he was hyperventilating. 
The arterial pH was 7.58, the PC02 was 2.8 kPa (21 nnn Hg), and the bicarbonate 
concentration was 19 nuno]jL. The corresponding reference ranges are 7.35-7.45, 
4.65-5.98 kPa (35-45 mm Hg) and 22-32 mmolfL, respectively. This condition conld be 
described as a simple respiratory alkalosis (with partial metabolic compensation). At this 
point, a new element in acid-base diagnosis is introduced, i.e. the anion gap (the sum of 
the sodium and potassium - minus the sum of the chloride and bicarborlate concentra-
tions). The anion gap was elevated (33 meqJL, ref. range 7-17 meqJL) in the absence of 
any medication or therapy likely to increase the wuneasured anions, suggesting that 
metabolic acidosis was present. Because the anion gap is increased by 16 meqfL above 
the upper reference limit, with normal sodium, potassium, and chloride concentrations, 
a similar decrease in bicarbonate would be expected. However, the bicarbonate 
concentration was decreased by far less than 16 mmolfL, suggesting a '"hidden' underlying 
metabolic alkalosis. This fmding was consistent with the history of persistent vomiting. 
Thus, a triple acid-base disorder was present, i.e. respiratory alkalosis, metabolic acidosis, 
and metabolic alkalosis. Without the clinical information, the only way to detect this 
mnltiple disorder is by calcnlation of the anion gap. 
Case2 
A 60-year-old man who developed acute oliguric renal failure (4), was admitted in a 
confused state to the hospital after several days. The arterial pH was 7.19, the PC02 5.0 
kPa (38 mm Hg), and the bicarbonate concentration 14 mmolfL. This conld be described 
as a simple metabolic acidosis, which is consistent with the elevated anion gap (27 
meqJL) and the clinical history. In this case, the decrease in bicarbonate is reflected in 
an equal rise of the anion gap. Nonnally, this situation would trigger a respiratory 
compensation causing the PC02 to fall. In this patient, an expected PC02 of approx-
imately 3.8 kPa (29 mm Hg) can be calcnlated. The acrnallevel (5.0 kPa) suggests an 
underlying respiratory acidosis, which is most likely due to concurrent congestive heart 
failure. Thus a double disorder was present, i.e. metabolic acidosis and respiratory 
acidosis. Without clinical information, the only clue to the solution is the calcnlation of 
the nonnal amount of compensation. 
In these examples, a correct (physiological) acid-base diagnosis can be made which is 
based solely on the blood-gas values, the anion gap, and a knowledge of the nonnal 
amount of compensation. However, without the clinical information (artificial ventilation, 
medication) it is often impossible to conclude which is the ptimary disturbance and which 
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one is secondary. This in tum could lead to an erroneous calculation of the compensation 
a.1id therefore to faulty conclusions. Some researchers have therefore constructed two sets 
of acid-base intetpretations, one for the nonnal situation, and one for patients on a 
ventilator (5,6). 
Another problem in acid-base diagnosis is the choice of an indicator of metabolic 
changes. Commonly, the actual bicarbonate concentration is used, but this approach is not 
altogether correct, since this concentration is not independent of the carbon dioxide 
tension. Indicators that are independent of the PC02 are the standard bicarbonate 
concentration and the base excess. 
The standard bicarbonate concentration is the actual bicarbonate concentration which has 
been nonnalized to a standard PC02 of 40 mm Hg. The base excess is a measure of the 
total bnffering capacity of the blood. It is defmed as the base concentration in meqJL of 
whole blood as measured by titration with strong acid to pH 7.40 at a PC02 of 40 mm 
Hg at 37 oc when the hemoglobin is 100% saturated with oxygen (7). For negative values 
of the base excess, the titration must be carried out by strong base. 
The base excess is slightly dependent on the hemoglobin concentration and it can be used 
to calculate the amount of bicarbonate or acid needed to correct an acid-base disturbance. 
We have calculated the base excess at two hemoglobin concentrations and several 
combinations of pH and PC02• The results, which are sununarized in Table 4.1, show that 
at nonnal PC02? the base excess varies only slightly with the hemoglobin concentration. 
In the cases with a low pH? where bicarbonate administration is usually considered, the 
highest variation was found with high PC02 (8 kPa). A difference of 2.48 meqJL (roughly 
0.35 meqJL for each mmol Fe2•[L Hb) was found, while the base excess at a hemoglobin 
concentration of 10 mmol Fe2•[L is 10.0 meqJL. This condition is likely to occur less 
frequently than a low pH with a low PC02, in which case the variation was only 0.91 
meqJL with a base excess of -21.5 meqJL. 
The use of the base excess has been advocated by Scandinavian researchers, whereas 
American researchers tend to use the bicarbonate concentration (8). This may give rise 
to different interpretations? as can be seen from the following example. 
Table 4.1 The absolute difference (OBE, in meqjL) between the base excess values at two fixed 
hemoglobin concentrations (3 and I 0 mmol Fe2+/L) as a function of acidity (pH) and carbon dioxide 
pressure (PCOz. in kPa). 
pH 
PC02 
6BE 
7.40 
5.32 
O.Ql 
7.40 
2.70 
1.61 
7.40 
8.00 
1.96 
7.55 
5.32 
0.10 
7.55 
2.70 
2.42 
7.55 
8.00 
2.80 
7.15 
5.32 
1.46 
7.15 
2.70 
0.91 
7.15 
8.00 
2.48 
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Case3 
A 55-year-old man with carcinoma of the lung complicated by a superior vena cava 
syndrome was transferred from another hospital for emergency radiotherapy (9). At the 
referring hospital he had required intubation for a respiratory arrest that occurred shortly 
after admission. Just before transport he was reported to have 'normal blood gases'. 
During transport, the ventilation was maintained manually using an :inspired relative 
oxygen content of 100%. On admission, his arterial pH was 7.04, the PC02 13.9 kPa (104 
mm Hg), the bicarbonate concentration 27 mmo]/L, and the anion gap was 17 meq/L with 
normal electrolytes. This disorder can be described as a simple respiratory acidosis. The 
bicarbonate concentration is essentially the same as the expected 28 nunoljL, calculated 
for an acute respiratory acidosis (2). Assuming a hemoglobin concentration of 9 mmol 
Fe2•JL, a base excess of approxbnately -8 meqJL (ref. range -3 to +3 meqJL) and a 
standard bicarbonate concentration of 18 mmolfL (ref. range 21-25 mmolfL) can be 
calculated. Considering these values, and the anion gap which was at its upper reference 
limit, a slight element of metabolic acidosis was present. The high content of inspired 
oxygen abolished the hypoxemic drive, and thereby reduced the alveolar ventilation. 
Unfortunately, no lactate determination had been done. Thus, a double disorder was 
present, i.e. respiratory acidosis and metabolic acidosis. 
This case clearly demonstrates the advantages of using an indicator of metabolic changes 
which is less dependent on the PC02 than the bicarbonate concentration. It should be 
admitted tb..at the hemoglobin concentration is of some influence on the base excess: a 
concentration of 6 mmolfL would have given a base excess of -5 meqfL. Much criticism 
has been given to the use of this calculated base excess, because the C02 titration curve 
of blood in vitro differs widely from that of blood in vivo which is, to a high degree, 
dependent on intracellular buffering (10). In our opinion, this argument carries less weight 
than the dependency of the bicarbonate concentration on the respiration. Therefore, we 
have chosen to use the base excess as an indicator of metabolic disturbances (11). 
The interpretation of acid-base disorders is determined by only three parameters, i.e. the 
pH, PC02, and base excess and it is essentially the same as the one given by V allbona 
et aL (12). However, some modifications have been made. 
I. We have refrained from using the term "compensation·, because there is no way of 
knowing whether the patient has artificial ventilation or some other non-physiological 
stimulus to ventilation. Thus, a low pH, a low PC02, and a low base excess would be 
diagnosed as a metabolic acidosis and respiratory alkalosis instead of a metabolic acidosis 
with some degree of resp.iratory compensation. 
2. The term "mixed' is not used because it refers to the existence of multiple etiological 
factors. 
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3. A condition with low pH, nonnal PC02, and low base excess is diagnosed as a 
metabolic and respiratory acidosis instead of a metabolic acidosis. The nonnal PC02 in 
this case points to an absence of the nonnal respiratory reaction to a metabolic acidosis. 
The absence of this reaction is causing a respiratory acidosis, regardless whether its cause 
is airway obstruction, drug overdose, or artificial underventilation. 
4. We have included tenns for the deviation of only one acid-base parameter, in 
accordance with the recommendations of the ad hoc committee (13). 
Jn theory, 27 combinations can be made out of three parameters with three possible states 
(Table 4.2). Of these, 1 combination represents the nonnal situation, 12 are regnlar acid-
base disorders, 6 are deviations of only one parameter, and the re:maining 8 do not occur 
and have been termed ·non·<ienominable ·. 
Although we feel that polarizing between 'laboratory' and 'clinical' interpretations creates 
an unsound atmosphere, our diagnosis is nevertheless based on laboratory results only. 
This approach has often been attacked as being unrealistic, but we believe that it is yet 
a valid one, provided that the physiological basis and the restrictions to its application are 
kept fmnly in mind. 
We have not yet included the use of the anion gap into this system of acid-base 
diagnosis. The reasons for this are multiple and depend largely on organizational factors. 
Analysis of blood gases and of serwn electrolytes are done on different equipment, in 
different material, and at different times of the day. The results can be combined for 
evaluation either in a laboratory database or in a hospital information system. The 
decision to do data analysis at the location where the data are produced is a matter of 
Table 4.2 Proposed interpretation of acid-bose parameters. Abbreviations 
are the same as in Table 4.1. The signs -, n, and + denote values below, 
within, and above the reference range, respectively. 
pH PC02 BE Interpretation 
Any Metabolic acidosis and respiratory alkalosis 
n/+ Metabolic and respiratory acidosis 
+ n Respiratory acidosis 
n n n Normal 
+ n Respiratory alkalosis 
+ n/- + Metabolic and respiratory alkalosis 
Any + + Metabolic alkalosis and respiratory acidosis 
n n Acidemia 
+ n n Alkalemia 
n n Hypocapnia 
n + n Hypercapnia 
n n Hypobasemia 
n n + Hyperbasemia 
.A.ny other condition Non-denominable 
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communication efficiency and favors the use of a laboratory database. Furthermore, it 
should be !mown if the time of sampling is the same, which very often is not the case. 
Arterial punction is done by the medical staff, whereas venapuncture is done by the 
nursing staff. The arterial samples are brought on ice to the laboratory and are analyzed 
as soon as possible, but the venous samples are part of the large number of requests for 
analysis which is daily received. For this reason, the electrolyte values are !mown at a 
later time of day than the blood-gas values. It is this time of day which ultimately 
detennines the moment when a full acid-base diagnosis can be made. 
New blood-gas equipment has been developed, which also measures electrolytes in the 
same blood sample. Besides the advantage .in timing, there is also the adv:llrtage of using 
the same material. For potassium, a difference between serum and plasma has been 
reported, which results from the coagulation process (14). Unfortunately, most of these 
new instruments can analyze sodium and potassium but not chloride, thus preventing the 
calculation of the anion gap. Favourable exceptions are the instruments from NOVA 
biomedical and Ciba Coming. 
4.2 Evaluation of the proposed interpretation 
Some researchers have criticised the use of the base excess as being often misleading in 
acid-base diagnosis (15). Some examples used in this criticism are shown in Table 4.3. 
Table 4.3 Acid-base interpretation. Abbreviations are: HC03 =actual bicarbonate concentration, 
BE = actual base excess, M. and m. = metabolic, R = respiratory, Ac = acidosis, Alk = alkalosis, 
comp =compensation. Missed diagnoses using the interpretation of Table 4.2 have been underlined. 
pH PCO, Hco, BE Interpretation 
mmHg mmolfL megjL Schwartz This thesis 
1. 7.32 80 40 11 R.Ac (m.comp) M.Alk, R.Ac 
2. 7.!8 80 29 0 R.Ac Cm.comm, Md£. R.Ac 
3. 7.!2 80 25 -5 R.Ac Cm.comp), M.Ac M.Ac, R.Ac 
4. 7.4! 80 49 23 R.Ac (m.comp), M.Aik M.Aik, R.Ac 
L This interpretation can be considered to be correct. 
2. In this case, there are two opposite metabolic disturbances, leading to a nonnal base 
excess. Here, knowledge of the anion gap would have been useful to unmask the 
metabolic acidosis. It can also be detected by calculating the expected bicarbonate 
concentration for this chronic respiratory acidosis (37 mmoljL), which is 8 mmol/L higher 
than the actual level of 29 mmolfL. Comparison of the anion gap and the change in 
bicarbonate concentration could have revelled the compensating metabolic alkalosis. 
3. In this case, ouly the compensatory metabolic alkalosis is missed. To prevent this, the 
same solution as given for the second example can be applied. 
4. This interpretation can be considered to be correct. 
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There are several other well-documented cases in the literature (3,9,16,17). When these 
cases are considered, the necessity of knowing the anion gap is apparent once more. For 
example, in the 22 cases reported by Cohen and Kassirer, 16 were diagnosed correctly; 
of the remaining 6 cases, 4 would have been diagnosed correctly if the anion gap could 
have been used; one case had inconsistent data, and one case was a borderline problem. 
The use of only one metabolic parameter does not permit the sllnultaneous recognition 
of two metabolic disturbances (acidosis and alkalosis). 
By these examples, the importance of measuring the anion gap is emphasized once more. 
The above proposal for acid-base intexpretation without the use of the anion gap is not 
a definitive one, but should only be regarded as a primary step towards a more complete 
system. 
4.3 The need for systems offering acid-base interpretation 
1. In a study, 71% of the physicians questioned believed they did not require computer 
assistance for acid-base diagnosis (18). When actually tested, however, they were able to 
correctly identify only 39% of the acid-base problems, including mixed disturbances. 
2. In another study which was done by three emergency physicians, the correct response 
rates for single, double, and triple disorders were 86%, 49%, and 17%, respectively (19). 
The norrual situation was recognized in only 68% of the cases, whereas an included 
laboratory error was recognized in 19% of the cases. The questionnees were physicians 
at various levels of training from emergency medicine, internal medicine, pediatrics, 
surgery and family practice specialties. 
3. In a third study, a system for acid-base disorders was compared with the opinion of a 
<medical expert", which was used as a gold standard (2). Disagreement in only 22 out of 
194 clinical cases (11 %) was found, of which 14 were borderline cases. In the remaining 
8 cases, the physician had to admit that in fact the systems interpretation was right. 
4. In a fourth study, a system for disorders in fluid and electrolyte balance was developed 
that was superior to the junior clinicians in the identification of acid-base disorders (20). 
4.4 Systems for interpretation of acid-base disorders 
The development of computer programs for acid-base interpretation is now at least twenty 
years old (5). Cohen et aL combined the Siggaard-Andersen nomogram with the 
!mow ledge of the physiological response to acid-base disturbances in order to determine 
the acid-base status of a given patient. They calculated the percentage of physiological 
compensation provided that it is known whether the patient is on or off a ventilator. The 
data were entered on punched cards into an IBM 360 computer, prognnnmed in FORTRAN 
IV. Since then, many researchers have developed computer programs for acid-base 
intexpretation, in some cases including electrolyte disturbances (Table 4.4). Instead of 
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presenting a lengthy discussion of all publications, we will highlight some characteristics 
of these interpretative systems. 
4.5 Characteristics of interpretative systems 
The list in Table 4.4, which may not be complete, contains mainly systems for acid-base 
interpretation although some systems have been designed for fluid and electrolyte 
management as well 
The hardware used varies widely in capacity, ranging from a simple pocket-calculator to 
a powerful workstation. Systems that only do some calculations and comparisons may 
well be implemented on calculators with intermediate capacity, whereas the larger 
systems that apply forms of reasoning may need more powerful computers (workstations). 
Some of these systems are used on a time-sharing basis and can be consulted by 
Table 4.4 Systems for the interpretation of acid-base disorders. n.r. means not reported 
Programming language Hardware Remarks Lit. ref. 
FORTRAN IBM 360{75 5 
CAL n.r. 21 
n.r. IBM 7094 II 22 
n.r. IBM 360/50 12 
STRcomp, MUMPS, APL PDP-9/PDP-1D 1 23-26 
BASIC, COURSEWRITER. DP-15/GE-635 23-26 
n.r. Prog.lOl/Olivetti 27 
FORTRAN PDP-6 28 
n.r. Prog.!O 1/602/0livetti 29 
BASIC Radio Shack TRS-80 2 30 
LISP LISP machine 2, 3 31, 32 
n.r. n.r. 33 
BASIC HP 41C pocket 34 
n.r. IBM-XT, AT/Apple II/Ile 1, 4 35 
BASIC MPT/100 36 
BASIC n.r. 6 
PASCAL Apple 37 
BASIC Apple II 38 
n.r. IBM-PC 5 39 
BASIC IBM-PC 19 
PROLOG SUN-3/160 2,40 
n.r. Intel280/310 2, 6 20 
1. Available from the author 
2. Additional interpretation of electrolytes 
3. A(cid) B(ase) EL(ectrolytes) 
4. Blood Gas Program 
5. Model Fluid Acid Base 
6. Shell Guru. 
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telephone (23). The progranuning languages that are used show a wide variability as well. 
Many of the progrnms have been written in BASIC, some in FORTRAN, there is one 
program in PROLOG (2), and one program applies a relational database (39). The input 
required by such systems may be entered interactively (keyboard) or automatically (on-
line). All systems listed in Table 4.4 require interactive input. 
An important characteristic of an interpretative system is whether it uses clinical data or 
not. It has long been held that no interpretation is possible withont clinical data, but 
nevertheless 6 progrnms from Table 4.4 can do without it (2,5,22,27 ,30,37). 
The interpretative systems can be classified according to their general approaclL The 
simpler systems are designed to do some straightforward calculations and comparisons. 
Most of them were developed at a time that many calculations had to be done by hand 
or by the use of nomogrnms, whereas in the modern analyzers many of these calculations 
have been incorporated. In addition, there is one system that is model-based (39). The 
complex systems use some sort of reasoning. There is one system which uses PROLOG, 
one of the artificial intelligence languages. 
Another characteristic is the pnzpose for which these systems have been developed. 
Broadly speaking this may be either training or consultation assistance. Some pmposes 
that have been mentioned are: back-up function for nights and weekends when expert 
opinion is not readily available, early warning, assistance in small hospitals, assistance 
in busy laboratories, intensive care and emergency departments, and education on the job. 
Another characteristic is the amonnt of appreciation that is encountered with the 
introduction of a system. Although the published data may have a favourable bias, the 
overall picture is positive. Some citations are: 'patient care favourably influenced'. ·well 
appreciated by the medical sta:ff'. 'at times outperforms its inventor·. An overview of the 
psychological factors in introducing these systems is given in the literature (15). Data 
about the evaluation phase of these systems is only scarcely available. In three 
publications, greater than 90% agreement is claimed with medical expert opinions. From 
an evaluation of 255 cases a specificity of 94% and sensitivity of 99% have been found 
(2). 
4.6 Development of an expert system for acid-base and electrolyte disorders 
In view of the well-defmed problem area and the need for inte:rpretative support. it was 
decided to develop an expert system CHEMPATH for acid-base and electrolyte disorders. 
It was developed using the shell Personal Consnltant Plus from Texas Instruments. This 
is a newer version of the shell used for LITHOS (cf.ch.2). When the consultation is started 
the user is presented with a screen layout where all acid-base and electrolyte parameters 
can be entered. This approach is more efficient than the time-consuming question-and-
answer approach where the data are asked for and entered sequentially. A frrst version 
of CHEMPATH was developed in co-operation with Dr. B.K. van Kreel at the Departtnent 
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of Chemical Pathology, Erasmus University Rotterdam, Rotterdam, The Netherlands. 
CHEMPATH is designed to deal with three types of input: blood-gas data, electrolyte data, 
or a combination of these. There are rule groups for acid-base analysis, for hypo- or 
hypernatrernia, and for hyponatremia or hypokalemia in combination with blood-gas 
measurements. Apart from the serum sodium or potasshun concentratio~ other analytes 
may be required such as senun chloride (to calculate the anion gap), or the urine 
osmolality. This creates another difficulty in the application of such a system. Blood-gas 
data and electrolyte values may have been measured, but the urine osmolality may be 
unknown (this is !mown as the problem of missing data). ln such cases, CHEMPATH gives 
a list of all diagnoses consistent with the input values, regardless of the value of the 
missing analyte. In this sense it is a restrictive system: the more data are lmown, the 
shorter the list of conclusions that are still consistent. The decision schemes in CHEMP A TH 
have been largely constructed from knowledge extracted from ref. 1, with some slight 
modifications. Figure 4.1 gives an example for the decision scheme for hyponatremia in 
combination with blood-gas data. There are, as has been mentioned, more decision 
schemes but the one shown in figure 4.1 is a representative example of the general 
approach. 
Conditions of hyponatremia should frrst be classified by serum osmolality. If this is 
decreased, a subdivision can be made by acid-base condition. Hyponatremia with a 
decreased osmolality and an accompanying metabolic acidosis can be further classified 
by serum potassium, serum urea, and urine sodimn concentrations. The fmdings between 
parentheses are those that are usually found with the corresponding disorder. 
This approach is of course subject to criticism. It will be of no use to a physician to have 
to request serum sodium, osmolality, and blood-gas values before arriving at the diagnosis 
'emesis·. Many of the other diagnoses will be apparent from their clinical symptoms. 
Another difficulty is the fact that the system is limited to single diagnoses, and is unfit 
to advise in mixed electrolyte disorders. This is a classical problem, often referred to as 
'the problem of the exploding search space'. CHEMPATH however, may be useful to those 
who want to test their knowledge in the course of their training in e.g. clinical chemistry 
or internal medicine. Additionally, it may serve to demonstrate how the spectrum of 
possibilities can be narrowed by a carefully aimed request sequence. As has been said 
earlier, there is also the organizational problem of collecting the data, and fm.ally it must 
be admitted that the LISP shell is relatively slow in the consultation process. 
These factors have led us to limit ourselves to the acid-base diagnostic part, and to 
translate this part into Turbo Pascal. ln daily routine, blood-gas analyses are done on 
ABL 330 equipment from Radiometer, Copenhagen, Denmark. The data are sent to a 
personal computer which is coupled via a local area network to the hospital information 
system. Because the software for the data communication has been written in Turbo 
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Pascal, the acid-base program has been translated :into the same language. 
Before this new course was taken, experiments had been done with a laboratory database 
in DBASE Ill. The data from analytical instnnnents which are coupled to a local area 
network were accumulated in a central database for interpretation by an expert system. 
Figure 4.1 Decision scheme for hyponatremia. An explanation is given in the text. 
Abbreviations are: Na = Sodium (mmof/L), K = Potassium (mmo/fL), U .:: urinary, Posm = serum 
osmolality (mosmoljkg), Posmeff =effective serum osmolality, SIADH =Syndrome of inappropriate 
AntiDiuretic Honnone secretion, +, n, and - = above, within, and below the reference range. 
Posm +jn I 
Serum urea + Serum urea -;n 
Posrneff - ;n Posrneff + 
Renal failure Pseudohyponatremia 
Posm- I 
Normal blood pH: 
Edematous states (UNa <lS) 
Hypxortisolism (UNa <lS) 
Hypothyroidism 
SIADH (UNa >20, Uosm 2:l00) 
Reset osrrostat (UNa <20, UOS!n <lOO) 
Prillm:y polydipsia (UOS!n <lOO) 
Metabolic alkalosis: 
Diuretics 
Ertesis (Bicartlonate ++) 
Nasogastric suction (Bicarbonate ++) 
Metabolic acidosis: 
Serum K + 
serum urea+ 
Renal failure 
serum K n 
Serum urea+ 
Renal failure 
Serum K-
Diarrhea (UNa <l5) 
Serum K + 
Serum urea - jn 
Mrenal insufficiency 
Serum K n 
Serum urea - ;n 
Mrenal insufficiency 
Diarrhea 
Intestinal tube drainage 
Intestinal tube drainage (UNa <l5) 
(UNa>20) 
(UNa>20) 
(UNa<l5) 
(UNa<l5) 
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The expert system shell Personal Consultant Plus is equipped with functions which enable 
it to read a DBASE Ill flle. Tills file, in turn, was tilled by a Turbo Pascal program 
included in the application software of the analytical instrument. However, this solution 
proved to be very slow and impractical compared to data handling that was completely 
regulated by a Turbo Pascal program. 
When a blood-gas analysis has been done, the analyst may generate a printed report with 
the sample number, the blood-gas data, and the laboratory diagnosis. This report may be 
handed over to the nurse who has brought the sample and has been instructed to ask for 
such an interpretation. Alternatively, a code representing the diagnosis may be sent to the 
hospital information system and be translated for those departments that are interested in 
this service. Because the venipunctures are done by the nursing staff, the use of bar-code 
labels has not yet been introduced in our hospital. This means that only the sample 
number and not the patient number is available to the personal computer and the network, 
nor is the time of sampling. This makes the problem of combining data from different 
apparatus a very difficult one. It is hoped that in the future the organizational aspects of 
the laboratory will be changed in such a way as to enable a practical and direct data 
interpretation. 
4.7 Conclusions 
In conclusion it can be said that the incorporation of a system for diagnostic support in 
acid-base and electrolyte disorders in a hospital laboratory is dependent on several factors. 
The most important of these is the simultaneous availability of data from different 
analytical equipment. Tills can be achieved by retrieval from a laboratory database, or by 
retrieval from the hospital information system. A system for the intetpretation of acid-
base disorders has been proposed, and it has been shown that the anion gap would be a 
valuable adjunct. An expert system for diagnostic support in acid-base and electrolyte 
disorders has been developed, which, although not fully tested, has produced encouraging 
results with cases used for examination of the trainees in clinical chemistry. 
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Chapter 5 
MULTIVARIATE REFERENCE REGIONS 
5.1 Introduction 
The theory of multivariate analysis for the detennination of reference ranges has as yet 
found limited application. For an introduction to multivariate analysis the reader is 
referred to the work of Albert and Harris (1). Thus far, this theory has been used for the 
calculation of multivariate reference ranges from healthy populations (see further), for 
multivariate delta checks (2,3), and for discriminant analysis. 
As has been stated in chapter 1, the use of multivariate reference ranges is most useful 
with variables that are appreciably correlated. In this chapter, only Gaussian distributions 
will be discussed. For an n-dimensional Gaussian distribution, the volume V containing 
95% of all observations is given by ( 4): 
(x'(n) )n/2 1C n/2 n v = o.os II <u .J ff 
r (n/2 + 1) , ' (eq. I) 
where x2 denotes the Chi-square function, u, is the standard deviation of the i-th 
distribution, r is the ganuna function, and p denotes the detenninant of the correlation 
matrix lrijl, where rij is the correlation coefficient between the i-th and the j-th variable. 
The volume V is represented by an ellipsoid in hyperspace. For the bivariate case this is 
an ellipse, and equation I reduces to 5.99 11: u 1 u2 1(1 - r\,). This means that for a pair 
of variables with correlation coefficient 1, the area is zero (straight line). The area is 
maximal for a correlation coefficient 0 (circle). Therefore, the difference in area between 
a double univariate reference region and a bivariate reference region increases with 
increasing correlation coefficient; this also holds for higher dimensionalities. It is this 
difference in area which is one of the important properties of multivariate analysis. 
For an univariate Gaussian distribution, a fraction 0.95 of all observations is found within 
two standard deviations (2cr) of the mean value. encompassing a range of 4cr. If two 
independent univariate distributions are considered. the combined reference region can 
be visualized as a rectangle. If the sides of the rectangle have a length of 4cr 1 and 4cr2 
(the indexes representing the variates), then a fraction of 0.952 = 0.90 of the observations 
will be located in this rectangle. lf a fraction 0.95 (= 0.9752) is desired, then the sides 
must be enlarged to 4.48cri. In this case the area within the rectangle is equal to 4.482 
0'1 0'2. 
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According to equation 1, the area within the bivariate reference ellipse is 5.99 1t cr1cr2 for 
uncorrelated variables. This is 94% of the area of the combined univariate rectangle. For 
three uncorrelated variables this percentage decreases to 84%. For any given dimension-
ality, this fraction decreases with an increasing correlation coefficient. 
Jn a two-dimensional distribution four types of observations can be distinguished (Figure 
5.1): 
1. notma! both univariate and bivariate 
(inside rectangle and ellipse) 
2. abnormal both univariate and bivariate 
(outside rectangle and ellipse) 
3. bivariate notma! yet univariate abnormal 
(inside ellipse, outside rectangle) 
4. univariate nonnal yet bivariate abnormal 
(inside rectangle, outside ellipse) 
2b 2a 2b 
3a : 3b 
------------------+-----------
: 4 
----------:3- ---------------
2a 1 2a 
4 
3a: 
---------------- 3t,;--3a- ---- ------------~------------------
' 
2b 2a 2b 
Figure 5.1 Classes of observations with two measurements. 
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The larger the correlation coefficient, the larger the area available for category 4 
measurements. It depends entirely on the behaviour of both variables in pathology if it 
is likely that values in tills area are found. If tills is the case, a gain of diagnostic space 
has been attained (clinical advantage). If not, a gain of space for plausibility control has 
been attained (laboratory advantage). 
Application of the general formula to the trivariate case yields for the volume V of the 
95% ellipsoid (2): 
(eq. 2) 
5.2 Multivariate reference regions obtained from healthy populations 
Several authors have reported correlations between clinical chemistry variates obtained 
from healthy individuals. Table 5.1 gives some examples of the highest correlation 
coefficients. 
The reduction in reference area can attain high values. For the combination of total lactate 
dehydrogenase (LD), heat stable LD, and aspartate aminotransferase, a 50% smaller 
reference range was reported. as compared to the univariate region, even with correlations 
not exceeding 0.42 (10). 
Table 5.1 Absolute correlation coefficients (r) benveen, and the number of observations (n) of 
clinical chemistry variates, obtained from healthy individuals. 
Variables r n Lit. ref. 
LD- HBD 0.97 !25 5 
Chloride - Total C02 0.75 250 5 
ALAT-ASAT 0.72 !979 6 
PavC02 - Hco,- 0.72 25 7 
Total protein - Albumin 0.65 3!3 8 
Total calcium- Albumin 0.62 !979 6 
CSF IgG - CSF Albumin 0.60 !27 9 
Sodium - Uric acid 0.58 !979 6 
Direct bili - Indirect bili 0.54 205 !0 
Uric acid - Creatinine 0.54 284 !! 
Abbreviations are: LD o;:o lactate dehydrogenase, HBD o;:o hydroxybutyric acid dehydrogenase, CO., 
o;:o carbon dioxide, ALAT =alanine aminotransferase, ASAT =aspartate aminotransferase, Pavco: 
= arterialized venous carbon dioxide tension, HC03- = plasma bicarbonate, CSF = cerebrospinai 
fluid, IgG = immunoglobulin G, bili = total bilirubin. 
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5.3 Advantages and disadvantages of the multivariate approach 
The question as to under which conditions multivariate reference regions are most 
fruitfully applied, remains to be answered. For this, an inspection of the advantages and 
disadvantages of the multivariate approach is necessary. 
Multivariate reference ranges have originally been developed to reduce the high 
proportion of falsely abnormal results as seen with proftles of multiple (univariate) 
laboratory tests. As has been stated in chapter 1, the mnnber of falsely abnormal results 
rapidly increases with the number of tests under consideration. Tbis proportion is usually 
assumed to be I - (0.95)" where n is the number of variates (6,12), but this ouly holds 
for independent variates, which is usually not the case. 
The relative insensitivity of the multivariate model to univariate abnonnality of a single 
test has been evaluated (6). It has been shown that this insensitivity increases with the 
number of tests rmder consideration. In contrast, univariate deviations of tests which are 
highly correlated with other tests (e.g. ASAT with ALAT) are reflected much earlier in 
the multivariate result than deviations of tests that are not highly correlated with others 
(e.g. glucose). In other words, increasing the number of tests has a dampening effect on 
the sensitivity to single deviations, and the model is more sensitive to single deviations 
with tightly correlated tests. 
5.4 Some examples 
Some authors have reported the fraction of observations that are univariate abnonnal and 
multivariate normal (category 3, section 5.1) relative to the total number of results. 
Fractions of 4% have been reported for albumin and total protein in a population of 
patients (13) and 9% for a three-parameter thyroid profile in a population of healthy 
individuals (14). The probability that such observations occur has been shown to be 1.4% 
for tests with pairwise correlations of 0.6 (15). The same author has shown that this 
probability is relatively insensitive to the number of variables, up to five. 
In the opposite case (category 4 ), where the results of a number of tests are univariate 
normal and multivariate abnormal, the area where such observations may be located 
increases with the correlation coefficient. Applying equation 1 to the data from ref.l3, an 
area of 5.99 1t cr1cr2 I(! - 0.522) can be calculated for the ellipse, and an area of 4.482 
cr1' cr2' for the rectangle. If the standard deviations were equal, the area of the ellipse 
would be 80% of the area of the rectangle. Naus et aL found that 1.1% of the albumin 
and total protein measurements, obtained from a population of patients were in this 
category (correlation coefficient 052, ref. 13). Apparently, hardly any pathology that 
could lead to category 4 type of observations was present in this population. This in tum 
creates the possibility to use the multivariate approach in plausibility controL Category 
4 results may be found because of pathology (low probability in this case) or by 
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Table 5.2 Correlation coefficients as obtained from 'healthy' populations, in cases where 
multivariate analysis has been used to construct a reference region. 
Tests r n Lit. ref. 
PavC02 - HC03- 0.72 25 7 
Total calcium - Albumin 0.59 313 8 
CSF lgG - CSF Albumin 0.60 127 9 
LD- LDh- ASAT 0.42 0.38 0.16 200 10 
FT41 - FT31 - ln TSH 0.24 -0.19 -'0.09 3752 14 
Abbreviations are the same as in Table 5.1. LDh = heat-stable LD, FT4I = free thyroxine index, 
FT3I = free triiodothyronine index, ln TSH =natural logarithm of thyrotropin. 
laboratory error in one or more of the measurements. Hence the possibility of detecting 
laboratory errors may be increased by rerunning all category 4 results. 
In conclusion, multivariate reference regions are best used to reduce the m.nnber (and 
follow-up measurements) of false-positive univariate results in ·healthy• persons 
(laboratory advantage) and to increase the sensitivity for early detection of pathology 
(clinical advantage). 
In Table 5.2, some examples are given of cases where multivariate reference regions have 
been constructed from ·healthy· populations. 
5.5 Assumptions underlying the calculation of reference ranges 
In the preceding sections, the multivariate reference ranges as obtained from healthy 
individuals have been discussed. The use of test results obtained from diseased 
individuals to develop univariate reference ranges was already lmown, and has been 
subject to heavy criticism (16,17). 1bis criticism has been aimed at the use of the 
Gaussian model, the stability of the data, and the validity of the assumptions underlying 
the use of patient data: 
I. The distribution around the mode is Gaussian. 
For many tests this has been shown not to be the case, even in healthy populations. 
Hence, this assumption should be verified in the calculation procedure. Several methods 
for such tests exist; the result of this verification depends on the sensitivity of the 
statistical test that is used (18). If the distribution is not Gaussian, a transformation of the 
data is usually indicated to satisfy the above assumption. 
2. The Gaussian part of the distribution is stable and unaffected by variations in disease 
composition, age, etc. 
This of course cannot be guaranteed, and therefore these ranges will have to be regularly 
adjusted. Population shifts have been reported in the univariate approach (19,20). 
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3. The analytical accuracy and precision have been stable in the period of data collection. 
The validity of this assumption can be checked by means of quality control data of the 
laboratory where the data were produced. 
4. The resulting range reflects the range of 'healthy' results. 
In general, this is not true. It has been shown repeatedly that patient -based reference 
ranges are shifted away from the 'healthy' mean, and generally display larger standard 
deviations (16,21-23). Of course it should be remembered that the early developed 
methods for estimating such ranges were coarse (24) and have gradually been refmed 
(2!,25). 
Ouly this last point of criticism is specific for the use of patient data. The other points 
apply equally to the use of data from healthy populations, which is common practice in 
contemporary clinical chemistry. It will be clear that the above criticism also applies to 
the determination of multivariate reference regions from patient populations. 
Concerning the frrst point of criticism, according to Pepe et aL the use of a Gaussian 
distribution as a model is justified if (26): 
1. The measured value is influenced by many factors. 
2. The fluctuations caused by these factors are independent. 
3. The fluctuations have the same order of magnitude. 
4. The frequency of large fluctuations is low. 
For clinical chemistty measurements in general, the conditions l, 2 and 4 seem to hold 
(18). The third conditio~ however, is not always valid. The activity of an enzyme in 
serum, for example, is largely governed by its rate of 'production· and its clearance from 
the circulation. In pathological processes, the spillover rate is usually much higher than 
the clearance and therefore condition three is no longer valid. The reverse is true for 
albumin: the rate of loss in renal failure may largely exceed the rate of synthesis by the 
liver. 
It seems therefore reasonable to assume that variables which are regulated both at high 
and low values, are more liable to follow a Gaussian distribution than variables that are 
easily either 'gained' or 'lost'. This comment applies to the mode and the standard 
deviation of the patient distribution. These values are usually shifted away from those 
obtained from healthy persons. 
In general, patient-derived standard deviations are larger than their equivalents obtained 
from healthy populations. However, ideally, intra-individnal reference ranges from healthy 
persons should be obtained. These represent a refmement in that they are smaller than the 
ranges obtained from a healthy reference group as a whole, and hence offer an earlier 
detection of disease. Madias et aL have done a first step in this direction in a multivariate 
analysis of the plasma bicarbonate concentration and the arterialized venous carbon 
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dioxide pressure (7). They used a series of intra-individual measurements to construct a 
bivariate reference region, thereby eliminating the inter-individual variation from the 
reference distribution. 
5.6 Multivariate reference regions from patient populations 
Naus et aL were the frrst to calculate a bivariate range from a collection of patient data 
(13). They used a large number of test results (3840 pairs) and detennined the fraction 
that followed a Gaussian distribution. The characteristics of the reference ellipsoid were 
estimated by the method of Bhattacharya (27,28). They found a mean value of 71.9 g/L 
for total protein, 44.0 g/L for albumin, and standard deviations of 4.87 and 3.13 g/L, 
respectively, and a correlation coefficient of 0.49. Unfortunately, they did not report their 
conventioual univariate reference limits (mean ± 2 s.d.), but their results would lead to 
univariate 95% reference limits of 62-81 g/L and 38-50 g/L. This is in reasonable 
agreement with the 60-78 g/L and 35-50 g/L cited in a leading textbook (29). 
It must be emphasized that the multivariate patient-based reference region does not serve 
to detect if a patients results are normal (i.e. comparable to 'healthy' individuals), but it 
is devised to: 
1. Achieve a reduction in unnecessary follow-up of marginally deviating results (cost 
saving). 
2. Detect either early pathology or measurement error (clinical advantage and quality 
improvement of laboratory results). This is the case when observations are univariate 
normal, yet multivariate abnormal. 
3. Serve as a measuring device to compare the patients results to the whole group of 
patients, i.e. to identify those patients who seem to require most attention. 
5.7 Preliminary investigation of patient data 
The study of acid-base terminology described in chapter 4 prompted us to investigate the 
distribution of acid-base diagnoses over a hospital population during a period of one 
month (30). In 1350 cases, the normal condition (pH, PC02, and base excess within 
univariate reference limits) was found most frequently (32% of the cases, see figure 5.2). 
The most dominant acid-base disturbance was an uncompensated respiratory alkalosis 
(20% of the cases). In 21% of the cases, only one parameter was outside its univariate 
reference range. AJl other disturbances occurred with frequencies less than 8%. 
When the group with ouly one abnormal parameter was analyzed in more detail, a 
decreased PC02 was found most frequently (48%), followed by an elevated base excess 
(27%). All other single deviations occurred in percentages lower than 9%. 
A striking feature is the large proportion (21 %) of single deviations, which could at the 
time not be classified in terms of proper acid-base diagnoses. A similar phenomenon with 
PC02 [kPa] 
7.35 
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7.45 
BE= +3 meq/L 
BE= -3 meq/L 
pH 
Figure 5.2 Siggaard-Andersen diagram with grey areas of near-nonnal results. 
acid-base measurements has been reported elsewhere (31): In a series of 255 cases, 20% 
of the results were between 2 and 3 standard deviations of the univariate reference ranges. 
These data were denoted as equivocal, i.e. they could neither indicate nor exclude the 
presence of an acid-base disorder. The authors commented that follow-up results were no 
longer equivocal, i.e. the condition had either improved or deteriorated. Another 
remarkable similarity with our results was the high frequency of respiratory alkalosis 
(20%, the amount of compensation was not reported). We observed a frequency of 20% 
for uncompensated respiratory alkalosis. 
Adressing the same problem, other authors have used two concentric ellipses, for 
bicarbonate and PC02: one ellipse defming the normal region as stated by Madias et aL, 
the other arbitrarily defming the 'near-nonnal' cases (32). Details describing the ellipses 
were not reported. 
5.8 Theory of the multivariate reference region 
An n-dimensional Gaussian distribution is completely defmed by the means and the 
standard deviations of the n variables and the n(n-1)/2 correlation coefficients. In an 
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n-dimensional space, the loci of the points of equal probability density are ellipsoids 
given by: 
(x - Ill C 1 (x - Ill = constant 
In this equation, 1J. is the true mean vector and C is the variance-covariance matrix. 
In general, 11 and C are unlmown and must be estimated from a set of observations. If m 
and S are the estimates of 11 and C, one may defme: 
as the non-Euclidian distance of an observation vector xi to the estimated mean m (33). 
As the equation indicates, points with equal distance to the mean are located on an 
ellipsoid. 
The probability of oc=ence of d2 will be denoted by P(d2). This probability follows an 
F-distnbution with N and n degrees of freedom, where N is the number of observations 
from which the parameters of the distribution were estimated and n is the dimensionality. 
For large N, the F-distribution may be approximated by a Chi-square distribution with n 
degrees of freedom. 
For the bivariate case the ellipsoid reduces to an ellipse. If a 1 and cr2 denote the standard 
deviations for the respective variables> and cr 1 > cr2, then the angle e between the major 
axis of the ellipse and the x-axis is given by: 
r u u tanE>= I 2 
(J2-0'2 
1 2 
Thus, the orientation of the ellipse is determined by the correlation coefficient r and the 
standard deviations cr,. If each variable is normalized by subtraction of the mean and 
division by the standard deviation, the ratio of the lengths of the major and minor axis 
is given by the expression: f(l + lrD I f(l - lrD which is equal to unity for a correlation 
coefficient zero. Graphically this is represented by a circle; non-scaled variables with 
uneqnal standard deviations would still produce an ellipse. 
5.9 Estimation of the multivariate reference region 
A procedure to estimate the characteristics of the distribution from a sample of 
observations in a n-dimensional case will now briefly be summarized. The details of this 
procedure can be found elsewhere (34). Starting point is a frrst approximation of the 
vector of the means and of the covariance matrix, e.g. as obtained from the total sample. 
The sample is then trinuned to those observations with a d2 smaller than an arbitrarily 
chosen limit. In the publication by Gelsema et aL, a value of 4 is used (34). From these, 
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new values for the mean and for the elements of the covariance matrix are then estimated 
in an iterative process. The standard deviations are corrected for the effect of trimming 
and it is verified whether the distributions of d2 of the subsample is compatible with a 
Chi-square distribution. If it is, the subsample is enlarged to the observations with d2 < 
4.5 and the estimation procedure is repeated. In subsequent steps the threshold value for 
d2 is increased by 0.5. The whole procedure is discontinued when the subsample is no 
longer compat10le with a Gaussian distribution. The last obtained compatible estimates 
then defme the Gaussian kernel of the total population. 
The number of observations needed to produce reliable results is considerable. It depends 
on the dimensionality of the model and the number, location and symmetry of the 
aberrant observations in the distribution. 
5.10 Multivariate reference regions for acid-base results 
With the procedure as summarized above, we have calculated reference ellipsoids for pH, 
PC02 and base excess from unselected data from the population in two hospitals (Table 
5.3). The data from the childrens hospital were mainly obtained from arterialized capillary 
samples, whereas the data from the adult group were measured in arterial samples. No 
corrections for patient temperature were made. 
Table 5.3 Characteristics of the reference ellipsoids for pH, PC02' and base excess (BE) for 
several age groups. Abbreviations are: n = nwnber of observations. s.d. = standard deviation, 
r = correlation coefficient, d = days, m = months, y = years. 
pH PC02 BE 
mean s.d. mean s.d. mean s.d. r r r 
n (kPa) (meqJL) pH, PC02 pH, BE reo,, BE 
Newborn 2261 7.307 5.813 -3.732 -0.715 0.549 0.187 
(<5d) 0.049 0.863 2.164 
Infant! 2646 7.301 6.395 -2.358 -0.541 0.601 0.344 
(5d-lm) 0.045 0.849 2.666 
!nfant2 2810 7.357 5.653 -1.010 -0.514 0.349 0.621 
(lm-ly) 0.041 0.950 2.944 
Child! 1365 7.381 4.853 -2.173 -0.409 0.687 0.378 
(l-5y) 0.041 0.568 2.537 
Child2 !072 7.387 5.013 -1.2!0 -0.512 0.672 0.285 
(5-18y) 0.038 0.525 0.246 
Adult 2402 7.438 4.770 0.240 -0.490 0.580 0.4!0 
(> 18y) 0.044 0.780 3.120 
In the adult population, 75% of the patients were classified as multivariate nomtal in 
contrast to 26% classified as univariate (conventionally) nonnal for the three variates. 
This means a threefold reduction in apparent pathological values in the multivariate 
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approach. The 'reference volume· in the univariate case is the volume of a rectangular 
box with sides 2 x 1.96 cr,, calculated to be 60.2 cr1cr2cr3. From equation 2 (section 5.1), 
the volume of the multivariate ellipsoid can be calculated to be 13.7 cr1'cr2'cr,'. lf the 
standard deviations were equal, this would represent a more than threefold smaller 
reference space. Usually, patient-derived standard deviations are larger than their health-
based counterparts, and this will reduce the difference in reference volumes. 
When the distribution of acid~base disorders over this data set was investigated, 
uncompensated respiratory alkalosis, concluded with the univariate procedure, was found 
most frequently (in 20% of the cases, consistent with the percentage found in an earlier 
set of 1350 cases, section 5.7). 
When only the observations outside the ellipsoid were used (i.e. multivariate abnormal 
results), this percentage decreased to 2%. In this multivariate abnonnal group, 
uncompensated respiratory acidosis was found with the highest frequency (5%), followed 
by uncompensated metabolic acidosis (4%). 
In 20% of the total number of cases there was only one parameter outside its univariate 
reference limit. This category was called non-denominable in a univariate approach (sec-
tion 5.7). By defmition, in the multivariate approach, all observations are denominable. 
5.11 Discussion 
With respect to the results, several remarks can be made. For the adult population, there 
is an obvious shift in reference ranges (Table 5.4). 
The population means are shifted towards higher pH and lower PC02, consistent with the 
high proportion of respiratory alkaloses in the hospital population. The standard 
deviations are approximately twice as large as those conventionally used (health-based). 
Larger ranges for patient-based populations have been reported before (e.g. 13,22). In 
another, smaller sample from the hospital population similar results were obtained (35). 
Currently, the characteristics of the reference ellipsoid in the population from another 
hospital is being examined. 
Table 5.4 Means and standard deviations of reference regions for adults. 
Multivariate (patient-based) Univariate (health-based) 
mean S.d. mean s.d. 
pH 7.44 0.044 7.40 0.025 
PC02 (kPa) 4.77 0.780 5.55 0.433 
BE (meqJL) 0.24 3.120 0 1.530 
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The frequent occurrence of respiratory aJJcalosis can be explained in several ways. The 
majority of the patients is artificially ventilated. According to clinical experience, these 
patients tend to feel better with PC02 values slightly lower than those in healthy 
individuals. They are thus kept in a state of slight overventilation. Furthermore, a 
situation of mild uncompensated respiratory alkalosis has been reported in anemia (36). 
Another possible cause is hyperventilation caused by anxiety (37). In normal persons, 
end-tidal mixed alveolar PC02 shows only minor fluctuations from the mean value. A 
single deep breath however, may lower this by 10 mm Hg or more and this situation 
takes 20-30 seconds to recover. Others have shown that arterial PC02 decreases to values 
between 2.4 and 3.6 kPa in 10 minutes of hyperventilation (38). Causes for this may be 
found in various factors such as fever (absence of post-analytical temperature correction) 
or non-physiologic stimuli to ventilation (medication, bacterial toxins). Finally, shifts in 
PC02 setpoint to lower values have been observed in high altitude adsptation (37), and 
in exercise (39,40). A similar shift in setpoint caused by illness may explain why patients 
tend to feel better with slight overventilation. The concept of setpoint will be discussed 
in more detail in the next section (5.12). 
The mean values Ior children are somewhat, but not dramatically shifted with respect to 
those obtained from healthy individuals (Table 5.5 and ref. 41). The base excess is not 
included because this information was not available in reference 41. 
5.12 Setpoint 
The term setpoint is used to indicate the physiological level at which a variable is 
regulated. The concept of setpoint is of utmost importance for a better understanding of 
the processes in pathology. Examples of setpoints in physiology are those for body 
temperature (42), the body weight (43), PC02 (39), osmolality (44), and the setpoint for 
calcium homeostasis (45). Examples of shifts in setpoints have been published. 
If a setpoint can shift from its normal value, there must be a path that is followed from 
the old to the new value. Furthermore, a path implies a direction in which the shift is 
Table 5.5 Means and standard deviations of reference regions for children. 
Multivariate (patient-based) Univariate (health-based) 
Age Mean S.d. Age Mean S.d. 
pH lm-ly 7.36 0.04 3m-2y 7.40 0.03 
!-5y 7.38 0.04 !-3y 7.38 0.03 
5-!8y 7.39 0.04 3-!5y 7.41 0.03 
PC02 (kPa) lm-ly 5.65 0.95 3m-2y 4.52 0.53 
!-5y 4.85 0.57 !-3y 4.52 0.53 
5-18y 5.0! 0.52 3-!5y 4.92 0.40 
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taking place. In the univariate case, the direction can be either an increase or a decrease. 
Well-defmed examples of such paths for the multivariate case can be found in the 
literature describing acid-base disorders (e.g. ref. 32). During a shift, there is either no 
setpoint or a setpoint that is variable in time. If the former were true, regulation would 
have been lost and various paths would be possible. This is in contradiction with the 
existence of a well defmed direction of the shift. If the latter is true, then the meaning of 
the term 'set' point is weakened. Indeed, small circadian fluctuations in temperature 
setpoint have been reported. 
It would appear that a setpoint is a compromise between the influence of macroscopic 
physiological factors on a microscopic regulatory level, and that the path followed during 
its shifting is the inevitable resultant from these macroscopic factors. In this view, the 
setpoint is a determi.nistic concept of the strive for homeostasis. 
It will be clear that this way of thinking exerts attraction on those who consider every 
patient as a nnique being. Others consider a patient as an individual that is part of a 
group of similar individuals, who are all subject to the same laws of nature. In the former 
way of thinking, the patient is considered as its own reference, leading to the deter-
mination of intra-individual reference values. In the latter, reference values are determined 
from the group as a whole. Yet, at least for acid-base physiology, these shifts in setpoint 
are known and can be calculated with their relatively narrow 95% confidence regions 
(32). This means that these shifts are comparable to a high degree between the members 
of a group of patients. 
In sununary, there seem to be three levels of refmement: the properties of a group of 
individuals (reference range), of a single individual (setpoint), and of this individuals 
condition (shifted setpoint). The shift in setpoint appears to be a temporary surrender of 
nature to the conditions imposed, in order to preserve physiological integrity. 
5.13 Evaluation of the multivariate model 
In order to investigate the possible usefuJness of the reference ellipsoid, we have 
incorporated the calculation of the Mahalanobis distance in the data-processing program 
connected to the blood-gas apparatus. On the basis of two data sets, the performance of 
the Mahalanobis distance in classifying abnormal blood-gas values was evaluated against 
the judgement of two clinicians. 
From the hospital population, 100 consecutive acid-base measurements were obtained 
with corresponding squared Mahalanobis distances. By defmition, a value of d2 exceeding 
7.8 was considered abnormal. The list of primary data (pH, PC02, and base excess) 
without other information about the patients was presented to a senior house officer, 
considered to be an expert in the field (indicated as '1st clinician" in Table 5.6). He was 
asked to mark the data sets which he considered to be abnormal. 
A second data set of 100 measurements was constructed, consisting of 95 serious acid-
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Table 5.6 Evaluation of acid-base data. 
MV =multivariate. UV = triple univariate. A squared Mahalanobis distance ::; 7.8 is considered 
norma[. a value > 7.8 abnormaL In the univariate classification, all values simultaneously within 
the reference ranges 7.35-7.45 for pH, 4. 7-6.4 kPajor PC02 and -3 to +3 meqjLfor base excess 
are considered normaL 
First set Second set 
1st clinician 1st clinician 
normal abnormal normal abnormal 
MV normal 49 13 5 0 
abnormal 5 33 11 84 
uv normal 27 4 7 0 
abnormal 27 42 9 84 
2nd clinician 2nd clinician 
normal abnormal normal abnormal 
MV normal 41 21 5 0 
abnormal 4 34 30 65 
uv normal 24 7 7 0 
abnormal 21 48 28 65 
2nd clinician 2nd clinician 
normal abnormal normal abnormal 
1st clinician normal 43 11 16 0 
abnormal 2 44 19 65 
base abnormalities (d2 values in the range 8.5-760) and 5 univariate nonnal cases. The 
same clinician was asked again to evaluate the list. 
In order to evaluate between-observer agreement, a second clinician from the same 
department was asked to evaluate both data sets in the same manner. The results of this 
experiment are summarized in Table 5.6. 
From this Table, the kappa statistics (±s.d.) can be calculated (46): 
Table 5.7 Evaluation of agreement: kappa values and standard devi-
ations. Abbreviations are the same as in Table 5.6. clin. =clinician. 
First set Second set 
First clin./MV 0.63±0.08 0.43±0.16 
First clin.fUV 0.40±0.09 0.58±0.13 
Second clin./MV 0.51±0.08 0.18±0.12 
Second clin.[UV 0.42±0.09 0.24±0.12 
First clin.{Second din. 0.74±0.07 0.52±0.10 
65 
The kappa statistic is a measure of agreement corrected for agreement by chance. Kappa 
equals zero if there is agreement by chance only, and unity if there is complete 
agreement. Although the value depends on the composition of the test set, it is unbiased 
by agreement by chance. 
From the kappa values in Table 5.7 it can be seen that in the frrst set the frrst clinicians 
judgement agrees more with the multivariate than with the univariate method (p < 0.06, 
ref.46), whereas the second clinicians judgement compares equally with both methods. 
This tendency to a multivariate approach of the first clinician was no longer apparent in 
the second set with the more serious cases. Furthermore, the second clinicians judgement 
seems to be influenced more than that of the frrst by the difference in composition 
between the two test sets, reflected by the much lower kappa values. The frrst of these 
(kappa ~ 0.18) does not reach significance compared to agreement by chance (kappa ~ 
0), whereas the second is just significant at a p value of 0.05. The agreement among both 
clinicians was the best for the frrst set and decreased significantly for the second set (p 
< 0.08). 
The relatively low measure of agreement of both clinicians with the conventional 
univariate method is striking. The frrst clinician said to weigh deviations in PC02 more 
heavily than deviations in the pH or the base excess. This seems a logical approach with 
artificially ventilated patients. 
This evaluation is of course too limited to warrant any definitive conclusion about the 
value of the multivariate approach. However, a preliminary judgement can be given in 
that it compares reasonably well with the judgement of two experienced clinicians who 
were given the test results only. 
5.14 The variation of the Mahalanobis distance in time 
Apart from the infonnation contained in the absolute value of the Mahalanobis distance, 
there is useful information contained in its change with time. This change is defmed as 
the ratio of the new minus the old squared Mahalanobis distance and the time difference 
in hours, calculated from two consecutive acid-base measurements. This change, which 
may be negative (improvement), zero (stationary), or positive (deterioration) will be 
denoted hereafter as v (velocity). The value of v is strongly dependent on the time 
interval: samples taken with an interval of 10 minutes may generate high values of v, 
whereas samples taken once each day may generate v values close to zero. Considering 
these arguments and the sampling frequency, data sets of several patients were obtained 
and evaluated for time differences between 1 and 12 hours. Table 5.8 shows the 
frequency distribution of v values in three patients. 
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Table 5.8 Frequency distribution ofv values(= Otifot). 
v [h-'l Patient 1 Patient 2 Patient 3 
< -20 4 2 4 
-20- -15 I 0 I 
-15- -10 4 I 3 
-10 - -5 6 I I 
-5-0 34 42 30 
0-5 31 44 35 
5- 10 9 2 5 
10- 15 I I I 
15- 20 2 0 0 
> 20 2 5 2 
Total 94 98 82 
Mean Ot [h:min] 5:22 5:02 3:30 
From Table 5.8 it can be seen that the majority of changes is found between -5 and +5 
h-L 69%, 88%, and 79% of the values, respectively. The distribution is centered around 
zero, and approximately the same number of positive and negative changes are fonnd. If 
this were not the case, the patients situation would be either predominantly deteriorate or 
improve. Deterioration or improvement is reflected in both the sign and in the relative 
magnitude of the positive and negative changes in Mahalanobis distance, respectively. 
The mean sampling interval is given because relatively shorter time :intervals Ot (reflected 
in a lower mean interval) may widen the distribution (causing higher ratios and therefore 
more values in both tails of the distribution of v). However, this is not the case with 
patient 3. The initial situation of this patient had been very serious: pH 7.25, PC02 3.6 
kPa, base excess -14 meqJL, and a squared Mahalanobis distance of 1013. This situation 
improved quickly on treatment. In this case, the lower mean sampling interval apparently 
reflects the ongoing concern for this patient, leading to frequent sampling, despite the 
absence of serious derangments. 
We conclude from Table 5.8 and similar observations that a reference change of 5 h-1 
appears an acceptable rough cut-off limit for sigualling rapid shifts in acid-base 
equilibrium. Such a change could occur in spite of a nonnal squared Mahalanobis 
distance, for example from 0.2 to 6.0 in one hour (v = +5.8 h-1). In such a case, an early 
sigualling of a rapidly deranging acid-base condition is possible, which enables the 
clinician to take preventive measures. In combination with the absolute value of the 
squared Mahalanobis distance, the possibility is created to alert the physician for four 
kinds of conditions: 
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1. deviating and unstable 
2. deviating but stable 
3. normal but unstable 
4. normal and stable 
In figure 5.3 a scatter plot is presented of paired squared Mahalanobis distance and 
velocity values. The general impression is that high d2 values are associated with high 
velocities (deviating and unstable), especially for the positive velocities. 
The four classifications mentioned above may be brought to the attention of the physician 
by presenting the measured sets in a colour code on a tenninal screen or a printed report, 
e.g. red for class l, yellow for class 2, blue for class 3, and green for class 4. Alter-
natively, a department may choose to be alerted to only a subset of these types of 
condition. The monitoring of the Mahalanobis distance changes with time may be helpful 
to reduce the number of UIUlecessary blood-gas measurements in intensive care units. 
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Figure 5.3 Scatter plot of the squared Mahalanobis distance and its change in time. 
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5.15 Conclusions 
The use of multivariate reference ranges in clinical chemistry can have advantages for 
both the laboratory and the clinic. The production of such ranges from large collections 
of patient data is possible, but the conditions for and limitations of this method should 
be kept firmly in mind. At the stage of investigation described above the torch was 
handed over to the department of Medical Informatics of the Erasmus University 
Rotterdam. Further lines of investigation are directed at: 
1. evaluation of the multivariate approach in a neonatal ward, 
2. evaluation of the multivariate approach in another hospital, and 
3. development of a multivariate approach to acid-base nomenclature. 
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Chapter 6 
EXPLORATION OF HEMO, AN EXPERT SYSTEM FOR 
HEMATOLOGY 
6.1 Introduction 
Anemia is a frequently encountered condition in medicine. It is defmed as a deficiency 
of circulating functional hemoglobin. The anemias can be classified on the basis of 
morphological characteristics (red blood cell size and color), or by physiological criteria 
such as erythrocyte production, erythrocyte degradation or blood loss. 
Conventionally, the human eye and microscope served to investigate the red cell 
morphology. Technological advances have permitted the use of hemocytometry, which 
combines greater accuracy and precision with shorter analysis time. Instruments 
employing optical or impedance measurement principles produce a large amonnt of 
information from a single blood sample. Typically, the hemoglobin concentration (Hb) 
is measured, the number of erythrocytes per volume (RBC) as well as their size 
distribution, the leukocyte count, the thrombocyte count, and usually some form of 
leukocyte differentiation. From these primary measurements, secondary parameters such 
as the mean red cell volume (MCV) and the red cell volume distribution width (RDW) 
are calculated. The latter is defined as the ratio of the standard deviation and the mean 
value of the erythrocyte volume distribution curve, expressed as a percentage. 
The subject of this chapter is to investigate the development of an expert system that 
supports the diagnostic process by automated interpretation of laboratory data and 
contributes to accelerated laboratory testing. 
Such a system will be of value in particular in interpreting results from patients in the 
diagnostic phase, usually at the time they make their fiiSt, policlinical visit to the hospital. 
Hemocytometrical data are commonly requested in these cases. The patient goes home 
after such a visit, and is generally requested to return after several weeks for follow-up. 
If necessary, further hematological parameters will be requested, evaluated, and so on. 
The evaluation of hospitalized patients is more complicated because it requires clinical 
information about recent surgery, transfusion history, and about the application of 
medication influencing hematological parameters. 
In the policlinical application, the automated data interpretation may result in a gain in 
efficiency, time, use of sample, and reduction in cost. The expert system should ideally 
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generate advice for follow-up measurements. If flatted by the physician in a quick 
response, the laboratory is enabled to use the remainder of the sample for snch additional 
measurements. Thus, all measured parameters are representative of the situation at one 
moment, instead of being separated by a large period in time (which may necessitate 
repeated measurements). This approach may also result in a reduction of the number of 
policlinical visits for each patient, since the physician will have more diagnostic 
information at the next visit, which provides him with a better defmed picture of the 
diagnostic problem. 
6.1.1 Physician performance 
In order to appreciate the need for a diagnostic support system, a literature evaluation of 
the quality of diagnostics is given below: 
1. In a study of 199 anemic patients admitted to the medical service of a university 
hospital, the recognition rate of anemia was examJned as a function of the hemoglobin 
concentration (1). Ouly at levels below 5.5 mmol Fe2'(L did the recognition rate reach 
100%. A quarter of all anemic patients was not recognized as such, and a fifth was 
recognized but either misidentified or not evaluated. Some medical teams were reported 
to identify most of the cases of anemia, whereas others rarely did. 
2. In a study of 728 anemic patients, 259 were judged to need diagnostic evaluation of 
the anemia (2). Of these, a flfth had diagnostic evaluations that were considered 
inadequate. The personal performance of the 26 medical interns in this study was 
expressed as the percentage of adequately evaluated patients, and varied from 25% to 
about 90%. The most common shortcoming of the incomplete evaluations was a failure 
to evaluate possible iron deficiency in normocytic patients. 
3. In a study of 30 cases of anemia, the mean percentage of agreement among six expert 
hematologists in grading their diagnoses into four classes of probability was ouly 48% 
(3). The individual grading of a diagnosis was called satisfactory if the other experts 
agreed, or if it was considered a reasonable alternative. This individual percentage of 
rating varied from 60% to 100%. With an expert system called ANEMIA, this percentage 
was 83% (3). 
4. In a study of 173 cases of anemia, two specialists in internal medicine who recently 
had followed a course in hematology, made the correct diagnosis in ouly 32% and 30% 
of the cases. However, the correct diagnosis was among the five diagnoses considered 
most likely in 68% and 77% of the cases (4). Corresponding figures for the expert system 
'ADH' were 53% (first) and 87% (among five) respectively. 
5. In another study, 7 cases of microcytic red cell disorders were presented to 17 expert 
physicians. Ouly 1 physician had the correct diagnosis in every case (5). All physicians 
correctly diagnosed at least 4 cases. 
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6. In a study of 53 cases with microcytosis and RBC > 5 x !012/L, in 41% of the cases 
thalassemia was not considered in the differential diagnosis by residents in internal 
medicine (6). A correct interpretation of the hemoglobin electrophoresis results was given 
in only 56% of the cases. Iron therapy was given in 17% of the cases. 
These literature studies clearly demonstrate that there is sufficient reason for the 
development of systems that offer diagnostic assistance in anemia. 
6.2 Analysis of the diagnostic process 
For the development of an expert system in hematology, the diagnostic value of generally 
applied tests was investigated and an analysis of request patterns was made. 
6.2.1 Selection of diagnostic parameters 
Definitions that will be used in this section are: 
Sensitivity 
The percentage of the patients with a disease having an abnormal test result (true 
positive fraction x 100). 
Specificity 
The percentage of patients without the disease having a normal test result (true 
negative fraction x 100). 
Positive predictive value 
The patients .with the disease and an abnormal test result, expressed as a percentage 
of all patients with an abnormal test result. 
Negative predictive value 
The patients without the disease and with a normal test result, expressed as a 
percentage of all patients with a normal test result. 
The introduction of hemocytometry led to the availability of several parameters describing 
characteristics of the population of erythrocytes. By defmition, the MCV is used to 
differentiate between microcytic, normocytic, and macrocytic anemia. The RDW, an 
objective and precise measure of anisocytosis (7), was claimed to differentiate between 
iron deficiency and heterozygous thalassemia. Finally, the reticulocyte count is 
indispensable in distinguishing hyper-proliferative from hypo-proliferative anemias. 
Several authors have published diagnostic fmdings in correlation with MCV and RDW, 
with sometimes conflicting results (8-12). 
The interpretation of these studies requires some caution (13). The factors influencing the 
prevalence of a disease in the selected pcpulation, should be carefully considered. The 
selection of patients in a study is of importance, e.g. hospitalized patients, policlinical 
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patients, 'healthy' subjects being screened for disease or a mixture of these. Ethnic and 
racial composition should be known, as well as age and sex distribution. Some authors 
present results obtained from unselected hospitalized patients, others have selected only 
patients with anentia, and still others selected patients with nticrocytosis regardless of the 
presence of anemia. Also, the co-occurrence of other diseases known to affect the 
screening measurements should be considered. The choice of the analytical instrument 
and methodology may also affect the resnlts: the calcnlation of the RDW in the early 
types of cell counting instruments differs from the way it is done at present (14). Some 
authors use different methods of demonstrating the presence of a disease (e.g. in case of 
iron deficiency: the serum ferritin concentration, bone marrow iron staining, transferrin 
saturation or iron therapy responsiveness). The choice of the decision threshold to 
distinguish between a normal and an abnormal test resnlt has a major influence on the 
resnlts. 
6.2.1.1 The mean erythrocyte volume and red cell distribution width 
The following studies give an impression of the diagnostic utility of these parameters. 
1. MCV in screening for nutritional deficiencies 
In a series of 69 iron deficient patients, only 61% were identified on the basis of a low 
MCV (15). A low mean corpuscular hemoglobin concentration performed slightly better 
(74%). In the latter case, the positive and negative predictive values were 65% and 80%, 
respectively. In the same study, 89 patients were vitantin B12 deficient, of which only 
48% could have been detected by a high MCV. The positive and negative predictive 
values were 32% and 93%, respectively. Also, 38 patients were folate deficient, of which 
37% would have been detected by a high MCV. For this test, the positive and negative 
predictive values were 25% and 89%. No data were included about the occurrence of 
other causes for macrocytosis in this Irish population. 
2. MCV and RDW in iron deficiency 
In another study, a sensitivity of 56% was found for a low MCV as a screening parameter 
for iron deficiency anemia (prevalence 8%) in screening a population of Japanese female 
students (16). The claimed specificity of 96%, however, does not take the 'borderline' 
cases (prelatent and latent iron deficiency) into account as 'absence of disease~, and thus 
the true specificity is expected to be lower. In the same study, the RDW had a sensitivity 
of 77% and a specificity of 83% for iron deficiency. Unfornurately, no information was 
given about the prevalence of thalassentia or hemoglobinopathy in tltis population. 
3. RDW in nticrocytosis 
In a study of patients with nticrocytosis, 94% of the patients with iron deficiency had an 
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elevated RDW (11), which was also seen in 48% of the patients with thalassemia. The 
prevalence of thalassemia in this Hawaiian population with microcytosis was high (53%) 
compared to that of iron deficiency (37%). The differentiation between these disorders 
is important because the thalassemics are at risk of receiving unnecessary and even 
potentially harmful iron therapy. 
The RDW has been shown to correlate positively with the reticulocyte count in a group 
of 1121 Jamaican individuals with homozygous sickle cell disease, but not in 344 
individuals with hemoglobin SC disease (17). Almost all patients in the former group had 
an elevated RDW. 
4. MCV and RDW in iron deficiency and heterozygous ~-thalassemia 
In a thorough Italian study of outpatients with microcytosis, 33% of the patients with iron 
deficiency had RDWs which were in the range for ~-thalassemia trait (18). Only 28% of 
the thalassemia patients had RDWs within the normal reference limits, the remainder had 
higher RDWs. Of the thalassemia group, 23% were not anemic. The authors preswne that 
the thalassemia patients with more severe anemia tend to have higher RDW. This has also 
been presumed elsewhere (8). 
5. RDW in anemia of chronic disease and in thalassemia trait 
In a Californian study, an increased RDW was found in 66% of the patients with 
heterozygous !3-thalassernia, in 32% of the patients with anemia of chronic disease, in 
34% and 53% of the female and male patients, respectively, with a-thalassemia trait (19). 
A review of the literature on RDW values in disorders which may present with 
microcytosis resulted in the information presented in Table 6.1. 
The conclusion from these data is that the ranges of RDW for these conditions show wide 
overlap and do not pennit a differentiation between these disorders, in particular not in 
individual cases. Ouly very high RDWs (e.g. >25, from Table 6.1) associated with 
microcytosis may be attributed to iron deficiency, and only if other conditions causing 
such high values have been excluded (homozygous sickle cell disease, sickle cell 
~0-thalassemia, HbSC, or HbH disease). 
Reconsidering the definition of the RDW, it is apparent that any mixture of two 
eryJrrocyte populations with sufficiently different mean red cell volumes will increase the 
RDW. Such a mixture may be composed of normocytic and microcytic (iron deficiency, 
chronic inflammation), normocytic ru1d macrocytic (vitamin B 12 deficiency), or microcytic 
and macrocytic cells (combined iron and folate deficiency). Since the RDW is the ratio 
of the standard deviation of the erythrocyte volume distribution curve and the MCV, its 
value will be influenced by both measurements. It is therefore not a pure measure of 
anisocytosis and the diagnostic value of this parameter is largely diminished. 
Another parameter has been proposed as a measure for red cell volume dispersion. This 
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Table 6.1 The red cell distribution width (RDW) in three disorders, which can produce 
microcytosis. The number of patients (n) and the range of possible values are given. 
Literature Iron deficiency ~-Thalassemia minor Inflammation 
reference 
n range n range n range 
gl4,1 67 (12.7-19.9) 16 (10.5-16.9) 28 (12.8-18.8) 
201 43 (11.3-29.9) 28 (12.9-18.6) 
2115.2 69 (17.2-33.5)3 67 (12.8-20.5)11 
2214,1 116 (10.0-36.7)4 186 (10.8-22.5)11 
1815.2 196 (!3.0-33.8)5 358 (12.5-21.7) 11 
2314,1 263 (11.5-23.9)6 445 (!3.1-17.2) 11 
111:5.2 68 (13.5-29.4)5 
1617,2 43 (12.2-19.9)7 
2416,2 17 (16.3-27.7)8 17 (14.5-18.4)12 
101:5.2 10 (16.8-25.0)9 13 (12.1-25.4) 
2515.2 76 (12.9-23.3) 10 22 (12.9-20.2)13 
This thesis152 104 (12.9-33.1) 
l. Mean± 2s.d. 8. Diagnosed by bone marrow iron or by 
2. Limit values serum iron, transferrin saturation, and 
3. Diagnosed by serum ferritin, transfer- iron-responsiveness 
rin, iron, erythrocyte protoporphyrin, 9. Diagnosed by serum ferritin 
and responsiveness to iron 10. Diagnosed by bone marrow iron or iron 
4. Diagnosed by serum iron and transfer- responsiveness 
rin 11. Diagnosed by HbA2 (normal iron stu-
5. Diagnosed by serum iron, transferrin, dies) 
and transferrin saturation 12. Unresponsive to iron 
6. Diagnosed by serum ferritin and iron- 13. Normal ferritin 
responsiveness 14. Coulter S Plus II 
7. Diagnosed by serum ferritin and trans- 15. Coulter S Plus IV 
ferrin saturation 16. Coulter C-1000 
17. Sysmex E-4000. 
is the absolute distribution width at half maximum (ADW05). Using an H6000/H601 
blood cell analyzer from Technicon Instruments, a specificity of 92% and a sensitivity 
of 66% were obtained in screening a hospital population for a.- and ~-thalassemia trait 
(26). 
6.2.1.2 The reticulocyte count 
The reticulocyte count is an indicator of erythropoetic activity. It indicates whether the 
expected response to anemia, i.e. an increased eryt:hropoesis, has or has not occurred. 
Absence of this response points at bone marrow failure as a cause of the anemia. In 
contrast, if the reticulocyte connt is increased, the cause of the anemia is usually 
hemolysis or blood loss. This blood loss may be obvious, e.g. excessive menstrual bleed-
ing, or it may not. In the latter case, e.g. a gastro.intestinal blood loss may be revelled. 
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Therefore, an accurate reticulocyte count is of value in the recognition of these patients. 
The number of reticulocytes is expressed either relatively, as a percentage of the 
erythrocyte count, or absolute, as the number of reticulocytes per unit volume. Studies 
with radioactive iron have shown that with decreasing hematocrit, the residence time of 
these cells in the bone marrow is shortened and hence the number of peripheral 
reticulocytes increases (27). The reticulocyte count can be corrected for this shift in 
residence time and for the hematocrit value, resulting in a reticulocyte production index 
(27). Another refmement can be made by classifying the reticulocytes according to their 
RNA content, which decreases with cell age (28). 
The manual cmmting of reticulocytes is tedious and subject to a large imprecision. Inter-
laboratory variations of 25-48% have been found in the U.S.A. and in France, and similar 
intra-laboratory variation coefficients have been demonstrated (28-30). We have 
determined an analytical intra-individual variation coefficient of 18% (at a mean value 
of 3.3% reticulocytes) and an analytical inter-individual variation coefficient of 36% 
(from duplicate measurements). 
With the equipment that has been developed for automated reticulocyte counting, 
variation coefficients between 4% and 8% can be attained (28,31 ). These instruments 
provide the clinician with a more precise parameter to measure the capacity of the bone 
marrow to respond to the anemia. The important role of this parameter in the diagnosis 
of anemia is a strong argument for the introduction of a reticulocyte counter in the 
clinical chemistry laboratory. 
6.2.2 Discriminant functions 
The realization that one parameter is insufficient to distinguish iron deficiency from 
heterozygous ~-thalassemia, has led many to try combinations of parameters. It is 
important to realize that a discrimination between these two disorders is something 
different than screening a population to detect, e.g. ~-thalassemia minor. Most of the 
attention in the literature has been focused on the first problem. 
A discriminant function is a mathematical expression, in which several measurement 
parameters may be combined. For the problem described above, combinations of Hb, 
MCV, RDW, RBC, MCH (mean corpuscular hemoglobin), MCHC (mean corpuscular 
hemoglobin concentration), MPV (mean platelet volume), and PDW (platelet distribution 
width) have been proposed. In any given case, the value of such an expression in relation 
to a decision level detern::Unes which disorder is present. Thus, a result is offered which 
is dichotomous by nature (present or absent). This approach lacks flexibility, especially 
in the area where the respective probabilities are not very different. Also, the possibility 
of a combination of the two disorders is ignored. These two problems can be overcome 
by the use of a continuous scale of probability, such as is incorporated in an expert 
system shell in the form of certainty factors. Discriminant functions may be used to 
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calculate the probability of an intermediate conclusion in the reasoning process (32). 
The performance of discriminant functions in separating iron deficiency from ~-thalas­
semia minor has been evaluated (26,32,33). One publication presents a discriminant 
function to screen a 'healthy' population for heterozygous thalassemia (34). This function 
produces very few false positive and false negative results compared to five other existing 
functions. Unfortunately, few cases of iron deficiency were included in the evaluation 
data set, so its validity in screening mixed populations has yet to be proven. 
The lack of transferability of discrintinant functions between analytical instruments from 
different manufacturers has been discussed (32). 
6. 2.3 Analysis of the request pattern 
The patterns of requests of hematological parameters for policlinical patients with anemia 
were evaluated. To this end, a group of 105 anemic patients (39% men and 61% women) 
who had not been visiting the hospital for six months was investigated. The reference 
values used in this evaluation are the following: 
Hb (mmol Fe2.[L) 
MCV (fL) 
RDW (%) 
Reticulocytes (%) 
Reticulocyte index 
Reticulocytes (109/L) 
8.7-10.5 7.5-9.7 
82-100 
11.8-15.6 
< 2.0 
2.0-3.0 
9.2-114 7.8-106 
The Hb, MCV and RDW were measured on a Coulter S plus IV cell counter, the 
reticulocytes were counted manually and expressed as a percentage of the erythrocyte 
count. Table 6.2 lists the frequency of the measurements. 
Table 6.2 shows that the measurement of Hb is almost always requested in this group. 
Therefore all measurements done by the cell counter are potentially available for use in 
an interpretative system. Traditioually the combination of Hb and Ht (hematocrit) is 
requested (91% in this group). However, the Ht is a derived parameter which provides 
little extra information over the Hb. Other frequently requested combinations were: Hb 
with Ht and leukocytes (67%), and LD (lactate dehydrogenase) with bilirubin (31 %). 
The relative lack of interest in the MCV and RDW is remarkable. Nevertheless, 24 
patients group did have an abnormal MCV, and 18 patients an abnormal RDW. 
Apparently the physicians hardly use these measurements in screening for disease. Also, 
the excessively low number of requests for ferritin, vitamin B 12 and folic acid is striking. 
It might be assumed that these investigations have already been done by the fantily 
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Table 6.2 Requests (in %) for hematology evaluation in a 
group of 105 polyclinical patients with anemia. 
Test % Test % 
Hemoglobin 94 Ferritin 5 
Hematocrit 92 Transferrin 5 
Leukocyte count 73 Iron 4 
Bilirubin 47 Lymphocytes 4 
LD 41 Monocytes 4 
Thrombocyte count 38 Granulocytes 4 
Erythrocyte count 15 Vitamin B 12 3 
MCV 14 Folic acid 3 
RDW 13 Reticulocytes 
physician or that these requests are not considered to be necessary before the cell count 
results are available. 
In order to test this hypothesis, follow-up measurements of either iron, transferrin, ferritin 
or vitamin B12 and folic acid in these patients were recorded over a period of 2 years. 
Iron, transferrin, or ferritin were measured in only 11% of the patients, and vitamin B 12, 
folic acid, or both in 14%. Of the follow-up measurements, 24% were done within 7 
days, 28% in 7-50 days, and 48% after periods longer than 50 days. Although 
retrospectively it is impossible to determine jf these measurements would have bee~ 
necessary, the usefulness of accelerated laboratory testing is emphasized. 
A request of LD and bilirubin to detect hemolysis is obvious, although, LD may also be 
used to detect a tumor or myocardial infarction. The most frequent combination of 
hematology requests and requests for other measurements was LD, bilirubin, alkaline 
phosphatase, and garnma-glutamyl transferase (GGT; 41% ), apparently to rule out 
disorders of the liver as a cause of a high bilirubin concentration. Of the 47 patients with 
bilirubin measurements, only 2 patients had an increased value (> 14 f!IDolfL). Some 
physicians (20%) left out GGT, possibly because they were not screening for alcohol 
abuse. 
In the groups mentioned above, the partitioning of the MCV and RDW results was 
investigated. The results are given in Table 6.3. 
A. The policlinical group 
The results of this relatively small group may not be representative for a large number 
of patients, however they do give an impression of the situation. The high frequency of 
anemias with a normal MCV and a normal RDW is striking. Within this subgroup, 30% 
of the patients had an increased leukocyte count, which may point to anemia of 
inflammation or infection. 
The frequency of a decreased MCV is much higher than that of an increased MCV. This 
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Table 6.3 Distribution of MCV and RDW results (in %) of three groups: 
A. 105 policlinical patients with anemia, B. 75 hospitalized patients with anemia and reticulocyte 
requests, C. 1929 randomly selected patients (hospitalized and policlinical) with anemia. 
MCV RDW A. B. c. 
Low 0 0 0 
Low Normal 10 1 5 
High 9 11 10 
Low 0 0 <! 
Normal Normal 69 56 50 
High 8 23 26 
Low 0 0 0 
High Normal 4 0 4 
High 0 9 5 
Low any 19 12 15 
Normal any 77 79 76 
High any 4 9 9 
any Low 0 0 0 
any Normal 83 57 59 
any High 17 43 41 
is in line with results from another hospital in the Netherlands, where 47% of the patients 
had nticrocytosis and only 3% had macrocytosis in a population of clinical and 
policlinical patients with anemia. 
B. and C. The hospitalized group and the random group 
Because the reticulocyte count was hardly requested in the policlinical group, hospitalized 
patients with requests for a reticulocyte count were selected. Of the 102 patients in this 
group, 75 were anemic (of these, 84% were women and 16% were men). A group of 
1929 hospitalized and policlinical patients with anemia and with requests for cell counting 
was taken for comparison. This group consisted of 40% women and 60% men. 
Of the anentic patients with reticulocyte requests, 79% had a normal MCV and 57% had 
a normal RDW, which is almost the same as in the large random group. As many as 83% 
of the anentic patients with reticulocyte requests had normal reticulocyte counts. Calcula-
tion of the reticulocyte production index revelled that only 1% of the patients had an 
increased index, 1% had a normal index, and 98% had a decreased index. This distri-
bution of results was exactly reproduced when prospective reticulocyte counting was done 
in a group of 100 hospitalized patients with Hb concentrations below 6.4 mmol Fe2+fL. 
A difference in distribution of RDW between the group of hospitalized patients and the 
policlinical group is expected. Adequate therapy in the hospital may cause an increase in 
the reticulocyte count, which leads to a new population of normocytic cells and thereby 
to an increase in RDW. The percentage of increased RDW is indeed higher in the 
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hospitalized group than in the policlinical group (43% and 17%, respectively). 
On further analysis of the large random group, a difference according to sex became 
apparent. The frequency of microcytosis was higher in the subgroup of women (24%) 
than in the subgroup of men (9%). The same sex-related clifference was also observed in 
the policlinical group: 27% of the women had microcytosis compared to 13% of the men. 
A possible cause for this clifference could be an increased loss of blood by menstrual 
bleeding with iron deficiency as a result. In the large random group, the percentage of 
high RDW was essentially the same for both sexes (39% for men and 43% for women). 
6.3 Anemia of inflammation 
Inflammation is a frequent cause of anemia. In approximately 75% of the patients with 
this type of anemia the MCV is normal and in 25% it is decreased. An increased 
haptoglobin concentration and a transferrin concentration in the low normal range are 
signs of an acute phase reaction and can improve the detection rate of this anemia. 
Because ferritin is a positive acute phase protein, it can only with caution be used as an 
:indicator of iron stores. 
In a group of 100 patients with transferrin <62 }lmolfL and ferritin > 50 jlg/L, a 
decreased folate concentration ( < 7.1 nmolfL) was found with a remarkably high 
frequency (50%). In a subgroup of 39 patients satisfying the above conditions and with 
serum iron <10 }lmolfL (inflammation), this frequency was essentially the same (54%). 
The reason for this high frequency is unknown. In the reverse situation, 54 patients with 
decreased folate had the above constellation of transferrin and ferritin values in 31% of 
the cases. 
A group of 48 patients with rheumatic arthritis (satisfying the ARA criteria) was taken 
to study anemia of inflanunation. This group was subdivided in a group with iron 
deficiency (grade 1 or less stainable bone marrow iron), and a group without iron 
deficiency (more than grade I bone marrow iron). Table 6.4 shows the characteristics of 
both groups. 
In this group, the frequency of a decreased folate concentration (23%) is lower than found 
in the group of 100 patients mentioned above (50%). An explanation could be the 
presence of diseases with a high rate of cell turnover, or folate antagonist chemotherapy 
which depresses the folate concentration. Indeed, in the large group, 66% of the patients 
had a ferritin concentration exceeding 300 !J.g{L, which may be caused by malignancies. 
However, the frequency of a decreased folate concentration in this subgroup was 47%, 
which is not significantly clifferent from that in the unselected group (50%). Therefore 
this effect must be due to a common characteristic within this group, presumably some 
effect of the inflammatory reaction. 
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Table 6.4 Characteristics of patients with anemia of inflam-
mation (Hb < 7.4 mmol Fe2 .,../L). 
Number of patients 
Women/men 
MCV <80 fL 
80-96 fL 
>96 fL 
MCH <1600 amol 
1600-2200 amol 
>2200 amol 
Iron <llj.J.molfL 
Transferrin <62 or >62J.Lrnolfl 
Ferritin <50 or >50 J.lg/L 
Folate <7 nmoljL 
Vitamin B 1z <150 pmolfL 
Reti.prod.index <2 or 2-3 
6.4 Development of the expert system 
Iron sufficient Iron deficient 
26 
!9j7 
I 
24 
2 
11 
15 
0 
25 
26/0 
3/21 
6 
5 
22/2 
22 
17/5 
12 
8 
2 
!5 
7 
0 
22 
15/7 
18/2 
5 
5 
18/2 
When hematological disorders are considered, the hemoglobin concentration is almost al-
ways the first parameter to be evaluated. In the expert system HEMO, three domains have 
been set up: one for Hb below the reference range (ANEMIA), one for Hb above the refer-
ence range (POLYHEMIA), and one for Hb in the reference range (NORMOHEMIA). Various 
reference ranges, depending on sex and age were implemented. Because of the high fre-
quency of anemia, efforts have been mainly directed at the development of this domain. 
The most practical fust step in the diagnosis of anemia is the differentiation on the basis 
of MCV. Although its discriminating value is limited (section 6.2.1.1), it is a reasonable 
choice. The next step is the measurement of the reticulocyte count, to provide infonnation 
about the ability of the bone marrow to respond to the existing Hb deficiency. In Table 
6.5 the structure of the domain ANEMIA is given. 
The disorders in Table 6.5 must be confiimed by appropriate tests, such as serum 
ferritine, and serum iron for iron deficiency, vitamin B 12 or folic acid for the correspond-
ing deficiencies, LD and bilirubin or haptoglobin for hemolysis, hemoglobin electro-
phoresis for thalassemia, bone marrow examination for sideroblastic anemia or bone 
marrow insufficiency. Starting with a complete blood count and a reticulocyte count, 
HEMO indicates which tests seem most appropriate to perform next. 
6.4.1 Subdomain Chronic hemolysis or blood loss 
The conclusion chronic hemolysis or blood loss is completely dependent on an elevated 
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Table 6.5 Srrucrure of the subcontext ANEMIA (decreased Hb). 
MCV Reticulocyte co\Ult 
increased normal/decreased 
normal normal/decreased 
decreased normal/decreased 
any value increased 
Interpretation 
Vit.B 12 deficiency 
Folate deficiency 
Bone marrow insufficiency 
Sideroblastic anemia 
Iron and folate deficiency 
Acute hemolysis/blood loss 
Bone marrow insufficiency 
Sideroblastic anemia 
Iron deficiency 
Thalassemia 
Inflammation 
Chronic hemolysis/blood loss 
absolute reticulocyte count and independent of the MCV. This section is subdivided on 
the basis of additional tests such as haptoglobin, lactate dehydrogenase, and total bilirubin 
(figure 6.1). 
The conclusion hemolysis is made if either haptoglobin is decreased (regardless of the 
value of LD and bilirubin), or if LD and bilirubin are increased. The conclusion is blood 
. loss if haptoglobin is normal or increased, and both LD and bilirubin are normal or 
decreased. In the case of blood loss, further examination should include a search for 
gastro-intestinal and gynaecological causes. We have not further extended this section. 
In the case of hemolysis, the direct Coombs test can indicate if there is innnune-
hemolysis. The temperature sensitivity of a positive Coombs test allows differentiation 
between warm antibodies, cold autoantibodies, and the presence of allo-antibodies. 
If the Coombs test is negative, an osmotic resistance test may detect a red cell membrane 
defect. If this test is normal, an acid Ham test is done to detect a paroxysmal nocturnal 
hemoglobinuria. If this is absent, a test is done to detect a deficiency of one of the 
erythrocytic enzymes. A diagnostic system for erythrocyte enzyme tests has been reported 
(35). If the erythrocyte enzymes have normal activity, the remaining possibilities are a 
hemoglobinopathy, or an anemia caused by hepatic disease. The former is confirmed by 
hemoglobin electrophoresis, and the latter will have become apparent at a much earlier 
stage from the hepatic enzymes. 
6.5 Evaluation of IIEMO 
The best way of evaluating a diagnostic support system is by prospective testing of its 
performance with a large number of cases, obtained from the population for which the 
85 
y 
y n 
n 
LD 
Haptoglobin 
Total bTiirubin 
abnormal? 
n 
y Erythr. n 
enzymes 
abn.? 
enzyme 
deficiency 
Figure 6.1 Structure of the section Hemolysisjblood loss. 
y 
Abbreviations are: LD =lactate dehydrogenase activity, HDN =hemolytic disease of the newborn, 
PNH = paroxysmal nocturnal hemoglobinuria. 
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system is developed. This requires the availability of laboratory results and corresponding 
diagnoses. Because such data were not available prospectively, the expert system HEMO 
was tested with retrospectively collected cases of anemia from the hospital population. 
For such cases, the identification number, date of diagnosis and diagnosis were obtained 
from the hospital registration system. The appropriate laboratory data, if present, were ob-
tained from the hospital information system. The combination of the Hb, MCV, RBC, and 
relative reticulocyte count is required for the use of HEMO. This combination was found 
in 115 cases which are shown in Table 6.7. Each of these cases was evaluated by HEMO. 
Table 6.7 Composition of the evaluation set and performance of HEMO. 
For explanation see text. 
Total Correct No final 
conclusion conclusion 1 
Iron deficiency 61 36 12 
Aplastic anemia 25 8 10 
Folic acid deficiency 10 2 3 
Auto-immune hemolysis 10 6 1 
Vitamin B 12 deficiency 3 2 0 
Thalassemia 3 1 0 
Sickle cell trait 2 0 2 
Spherocytosis 1 1 0 
1Correct conclusion still included 
I. Iron deficiency caused by chronic blood loss (61 cases) 
There were 61 cases in this group, none of which satisfied the criteria for anemia of 
inflammation: serum ferritin >50 flg/L, serum transferrin <62.7 f!IDOl/L (36). In 12 cases, 
HEMO did not reach an unambiguous conclusion, but in all of these cases chronic blood 
loss was among the diagnoses still considered likely at the end of the consultation. In the 
other 49 cases, shown in Table 6.8, an unambiguous conclusion was reached. 
Eight cases were diagnosed as bone marrow insufficiency. All of these had a normal 
MCV and a normal absolute reticulocyte count in spite of the anemia, a normal or 
increased serum ferritin and a normal or increased serum :iron. Transferrin saturation was 
13% or higher in 7 cases and unknown in one case. Iron therapy as a cause seems 
unlikely, because all of these patients did already have this combination of iron studies 
at earlier measurements. Therefore the diagnosis iron deficiency seems hardly valid in 
these cases. HEMO could have concluded blood loss in five of these cases, hemolysis in 
one case, and in two cases no diagnosis was possible (unlm.own haptoglobin). These 
potential diagnoses were not reached because the diagnosis of bone marrow insufficiency 
was made earlier and therefore the consultation had ended. This is a serious defect in 
HEMO which will be discussed further. In 4 cases, no diagnosis was given because the 
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Table 6.8 Conclusions made by HEMO in 49 cases 
of iron deficiency caused by chronic blood loss. 
Chronic blood loss 
Bone marrow insufficiency 
No diagnosis 
Iron deficiency 
Iron and folate deficiency 
Iron deficiency and hemolysis 
Hemolysis 
27 
8 
4 
4 
3 
2 
1 
condition of an isolated increased bilirubin concentration (normal LD and haptoglobin) 
was not included in the system. 
In 8 cases there was an accompanying decreased folate concentration. In three cases this 
was recognized, in five cases it was not: in two, the diagnosis iron deficiency was made 
earlier and the consultation had ended. In two cases the reticulocyte count was increased, 
which was not .included in the condition for combined iron and folate deficiency, and 
neither was a normal iron concentration (the last case). One patient with a coinciding 
decreased vitamin B12 concentration was classified as having bone marrow insufficiency 
(normal MCV). 
2. Aplastic anemia (25 cases) 
In 8 cases the correct conclusion (bone marrow insufficiency) was made, in 4 chronic 
blood loss, in 1 iron deficiency (low iron and ferritin), and in 1 iron and folate deficiency 
(based on low iron and low folate). In 10 cases an unambiguous diagnosis was not 
reached, but the correct conclusion was included in the fmal set. fu the aplastic anemia 
cases, 73% of the patients had a decreased hemoglobin concentration, a decreased 
leukocyte count (<4.0 x 109/L) and a thrombocyte count less than 200 x 109/L. The 
majority of the remaining 27% of patients had received a recent blood transfusion. In I 
case there was no final conclusion, but the correct conclusion had been ruled out. 
3. Folic acid deficiency (10 cases) 
In I case the diagnosis was folate deficiency, in 1 case iron and folate deficiency, in 5 
cases bone marrow insufficiency. fu two of these five cases the MCV was normal, which 
was not in the condition for folate deficiency, and in three bone marrow insufficiency was 
concluded earlier and the consultation had ended. In 2 out of 3 other cases the correct 
diagnosis was included in the fmal set. In one it was excluded because the increased 
vitamin B12 concentration was not in the condition for folate deficiency. 
4. Auto-innnune hemolysis (10 cases) 
In 5 cases the diagnosis was immune hemolysis, in 1 case iron and folate deficiency 
(based on low iron and folate) and hemolysis, and in 3 cases bone marrow insufficiency. 
In one of these three the cause was an isolated increased LD (normal bilirubin, unknown 
haptoglobin) which was not provided as a condition for hemolysis. fu two, bone marrow 
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insufficiency was concluded, before the result of the Coombs test could have been 
requested; however, an intermediate conclusion of hemolysis was added. In 1 case, the 
correct conclusion was in the final set. 
5. Vitamin B12 deficiency (3 cases) 
In l case vitamin B 12 deficiency was concluded, in 1 case vitamin B 12 and folate 
deficiency, and in 1 case bone marrow insufficiency (B12 deficiency not detected because 
of a normal MCV). 
6. Thalassemia (3 cases) 
In 1 case thalassemia was concluded. Two other cases were not identified because there 
was no hemolysis, which was in the condition for thalassemia. 
7. Sickle cell trait (2 cases) 
In the 2 cases of sickle cell trait, the correct diagnosis was included in the fmal set. 
8. Spherocytosis (1 case) 
The case of spherocytosis was correctly detected as an erythrocyte membrane defect. 
This evaluation of HEMO disclosed several imperfections. 
The most important of these is the fact that HEMO accomodates only one diagnosis for 
each case and will stop as soon as one has been found. Since not all diagnoses are 
mutually exclusive, some of them may be missed. Several combinations (iron and folate 
deficiency, iron deficiency and hemolysis) have been incorporated in separate rules. When 
the measurements satisfy more than one diagnosis (e.g. bone marrow insufficiency and 
folate deficiency), the outcome becomes dependent on which diagnosis is encountered 
first. This serious drawback can be overcome in several ways. 
The utility factor of the rules concluding the infrequently occurring anemias can be 
changed to a lower value. As a consequence these rules will be consulted only after all 
other rules have been tried. A better solution to this problem is to enable the system to 
accomodate several diagnoses at a time. Another possibility is to alter the affirmative 
approach to an exclusive approach: the system then reaches its fmal conclusion(s) by 
exclusion of all solutions that are incompatible with the measurements. Several minor 
imperfections can be classified as too tight conditions: e.g. folate deficiency is concluded 
only if the vitamin B 12 concentration is normal. Preceding therapy is likely to result in 
a raised vitamin B 12 level, so this should be included in the condition. 
Also, the possibility of a low folate and unknown vitamin B12 concentration should be 
included. Conditions with a normal haptoglobin concentration should also include an 
increased concentration, because of its behaviour as a positive acute phase protein. 
Conditions of isolated increases in LD or bilirubin should be incorporated. 
In many cases data were partially absent. The most important of these was the 
reticulocyte count (absent in 60% of 150 cases of iron deficiency by chronic blood loss). 
In the same group, the ferritin concentration was missing in 37% of the cases, and in 49% 
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the combination of iron and transferrin. Vitamin B 12 and/or folate concentrations were 
measured in 53% (80 cases), half of which were normocytic, and half microcytic. This 
led to the discovery of 16 cases with low folate, and 4 with low vitamin B 12 concen-
tration. Haptoglobin was measured in 31% of the cases. This parameter was not strictly 
needed by HEMO because LD and bilirubin were measured in almost all cases. 
6.6 Systems for automated interpretation of hematological disorders 
In recent years, large efforts have been made to construct interpretative systems for 
anemia. Table 6.9 presents an overview of systems for the automated interpretation of 
hematological disorders, mostly anemia. Systems for the diagnosis of leukemia, 
complement diseases and transfusion reactions have been excluded (For these, see chapter 
l, Table l.l). 
Table 6.9 Systems for the automated intaprerarion of hematological disorders. 
Abbreviations: n.r. nor referenced, comp. compatible 
Name Programming Hardware Remarks 
language/shell 
HEME n.r. IBM-n.r. 1 
KIRON FORTRAN Honeywell 6040 
ANEMIA, MICROANEMJA FORTRAN/EXPERT VAX ll/780, IBM-XT 
NEOANEMIA Common USP/KEE TI-EXPLORER 
n.r. n.r. n.r. 
ADH n.r. IBM-XT 2 
n.r. n.r./CSGP IBM-PC 
Consult-! CLS IBM-AT 3 
BCDE BASIC IBM-PC comp. 4 
BCDE2 BASIC IBM-PC comp. 5 
RBC BASICA IBM-XT 
Micro Hema screen BASIC Apple Tie 6 
n.r. n.r./MacSMARTS Apple Mac. SE 7 
n.r. n.r./vP-EXPERT IBM-PC 8,9 
1. Copyright International Business Machines Corporation 1975 
2. Aide a la Decision en Hematologie, Copyright Coultronics SA, France 
Literature 
reference 
37,38 
39 
3,40 
41 
42 
4 
43 
44,45 
46 
5 
47 
23 
48 
49 
3. Consult Learning System, registered trade mark of Patrick Consult Inc., Cincinnatti, Ohio 
4. Blood Count and Differential Evaluation, registered trade mark of Island Analytics, Galveston, 
Texas 1986 
5. Copyright Lea and Febiger 1988 
6. On-line coupled with a Coulter S Plus TI analyzer 
7. Registered trade mark of Cognition Technology Corporation, Massachusetts 
8. Paperback Software International, Berkeley, California 
9. Available from Dr. M.L. O'Connor 
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There are four groups which have been working for several years on hematological 
diagnostic systems: a French group (H6pital Henri Mondor, Paris; system ADH), an Italian 
group (University of Pavia; system NEOANE:MIA.), and two American groups (University 
of Texas, Texas; system BCDE, and University of Cincinnati, Ohio; system CONSULT-I). 
The other systems from Table 6.9 are either very early systems (HEME) or are developed 
for a small diagnostic area (microcytic anemia, thalassemia/iron deficiency, or 
myelodysplastic syndromes). The main characteristics of the four major systems are given 
in Table 6.10. 
Table 6.10 Characteristics of four major interpretative systems for anemia. 
n.r. means not reported. 
System ANEMIA ADH BCDE CONSULT-I 
Lit.ref. 3,40 4,42,43 46 44,45 
Disease entities 65 30 36 n.r. 
Use of a shell yes yes no yes 
Size of test set 100 180 182 84 
Correct diagnosis 
listed as first (%) 90 65 74 64 
Correct diagnosis 
among 1st three (%) 96 84 96 88 
Table 6.10 gives the number of disease entities each system is able to diagnose. This 
number may have increased since the moment of publication until present. All systems 
except one (BCDE) use an expert system shell. The size of the test set used in the evalu-
ation of these systems is given, which in some cases is rather small compared to the 
number of disease entities. The percentage of correct diagnoses in the evaluation found 
with the test set are given. As all systems display a list of possible diagnoses, the score 
for having the correct diagnosis among the first three has been included. All systems have 
been evaluated against human experts and performed equally or better. Hereafter, some 
additional characteristics of each of these systems will be discussed. 
1. ANEMIA 
This rule-based expert system was developed on a mainframe using the shell EXPERT. It 
was developed to assist the physician diagnosing anemias in an internal medicine setting. 
The system ANEMIA uses forward chaining (data driven reasoni11.g) and consists of 1250 
rules. It can accommodate 120 fmdings, among which are the results from a blood smear 
and from examination of the bone marrow. Its training set consisted of 200 cases of 
anemia. It is able to assist in the diagnosis of 65 disease entities, to provide a list of 
possible diagnoses and to give recommendations for management of the disease. The 
same group re-i.."'lplemented the knowledge of ANEMIA in a system called NEOANEMIA on 
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3..1.~ EXPLORER workstation from Texas Instruments, using the shell KEE. This was done to 
improve flexibility and user-friendliness. 
2.ADH 
The system ADH was developed on an IBM PC-XT. It was intended for adult pathology. 
It provides a list of possible diagnoses and it can propose follow-up tests. It can also 
accomodate data from a blood smear. The system was made using an expert system shell 
and uses the theorem of Bayes to calculate the probability of each diagnosis. Its training 
set consisted of 400 cases. The same group has developed an expert system for the 
diagnosis of myelodysplastic syndromes which additionally uses data from a bone m:h-row 
aspiration examination. 
3.BCDE 
This system was written in BASIC and runs on an IBM-PC compatible computer. The 
program accomodates data from the blood smear as well as clinical data like sex, race, 
and knowledge of recent chemotherapy or transfusion. The program was developed for 
the screening of adult patients. The system BCDE uses the results of multivariate analysis 
that were obtained with 8000 complete blood counts with known hematological status. 
The concept of ·nonnal blood count' was developed by multiva,:iate analysis of 1500 
blood counts from medical and nursing students. With this knowledge, a point scoring 
system was made indicating the probability of each diagnosis. The same group developed 
another progra..'lll, BCDE2, that discriminates between iron deficiency and heterozygous 
thalassemia. When evaluated, this system outperformed both a group of human experts 
and two discriminant functions based on erythrocyte indices. 
4. CONSULT-! 
The expert system CONSULT-I was developed for an IBM PC-AT using the shell Consult 
Learning System. It accomodates demographical data like age, sex, race, as well as data 
from the blood smear, ferritin, vitamin B 12, and red blood cell folate. The system uses 
pattern recognition techniques and likelihood ratios to construct a ranked list of diagnoses. 
Its training set consisted of 560 cases, among which were 60 cases of mixed a...11emias. 
The system is intended to be used in screening situations. Its results are reviewed and 
supervised by a pathologist. 
6.7 Discussion and conclusions 
We have developed a prototype expert system HEMO for diagnostic support in cases of 
anemia and for accelerated laboratory testing. This expert system requires less diverse 
input than the four systems described above. In HEMO, no data from the blood smear are 
used, nor have factors indicating the prevalence of disease or probability of conclusions 
been used. Demographical data (age and sex) and laboratory data are required, but no 
clinical data. The system obligatory uses the Hb, RBC, MCV, and a reticulocyte count. 
In its 66 rules, 21 diagnostic entities have been incorporated. The system runs on a PC-
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AT. Multivariate analysis is not used. Instead of creating a list of possibilities, one 
diagnostic interpretation is offered. The system can give advice for follow-up measure-
ments. If there are too many unknov.rn parameters, a list is given of the remaining 
diagnostic possibilities. 
In a limited evaluation, the system showed a reasonable performance. Although the 
system is not yet fmalized, many of its imperfections can easily be corrected. HEMO 
should be prospectively tested with a large number of policlinical cases. In this way its 
capability to give advice concerning additional measurements can also be tested. 
An expert system for the interpretation of hematological parameters is likely to function 
optimally in a screening environment, but it has been shown to be of value when applied 
to patients in a diagnostic phase. The hemocytometric measurements provide only a rough 
insight in the diagnostic diversity. e.g. in anemia with iron and folate deficiency, 
normocytic as well as microcytic cases have been found. In such cases, it seems 
reasonable to focus on the most common signs of a particular anemia (in this case 
normocytosis). The choice will depend on the cost-benefit analysis of each decision. In 
addition, the expert system may give further recommendations, such as folate measure-
ment in case of a low transferrin and high ferritin concentration. 
In conclusion it can be said that the spin-off of this project has been most valuable: the 
formalization of the logic in the diagnostic process, the realization of the necessity of a 
reliable reticulocyte count, as well as the realization of the restrictions to the use of the 
MCV and especially the RDW. Furthermore, a prototype expert system has been 
developed, which provides a logical and standardized approach to the classification 
of anemias and which may eventually contribute to a better health care service to the 
patient. 
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Chapter 7 
GENERAL DISCUSSION 
7.1 Introduction 
The subject of this thesis is to investigate how expert systems can be useful in clinical 
chemistry. An expert system is a computer program which can give advice in a well-
defined area of expertise and is able to explain its line of reasoning. An expert system 
can reason with uncertainty (1). 
We have developed three expert systems, all based on the empty shell 'Personal 
Consultant': LITIIOS, CHEMPATH and HEMO. Experiments with these systems have been 
performed in order to test the usefulness of this offspring from Artificial Intelligence. 
In clinical chemistry, expert systems can be useful in the following ways: 1. in the 
analytical process, 2. in the interpretation of clinical chemistry measurements, 3. in the 
guidance and acceleration of laboratory diagnostics, 4. in the troubleshooting of analytical 
instruments. An example of the frrst category is the expert system LITIIOS, developed for 
the interpretation of X-ray diffractograms of urinary calculi (2, cf. ch. 2 and 3). Others 
have used an expert system for the validation (plausibility control) of analytical results 
(3). Examples of the second and third category are CHEMPATH and HEMO, expert systems 
which give diagnostic support m acid-base and electrolyte disorders and in anemia, 
respectively (4, cf. ch. 4 and 6). The aspect of acceleration of laboratory diagnostics has 
not been tested. Examples of the second and fourth category are given in Table 1.1 (ch.l). 
Expert systems can be used withln various configurations, depending on the source of the 
input data. We have developed a system for acid-base interpretation which functions on-
line with a blood-gas analyzer (subunit of CIIEMPATH, ch. 4). On request, this system 
generates a printed report of the acid-base interpretation, including the squared 
Mahalanobis distance (ch. 4). In a second configuration, the system has been adapted to 
retrieve a patients historical blood-gas data from the hospital information system. The 
successive acid-base interpretations are presented on the screen and the corresponding 
squared Mahalanobis distances are graphically displayed as a rime series. In a third 
configuration. the data are retrieved from a laboratory database. We have developed a 
Turbo Pascal program functioning on a local area network, which fills a laboratory 
database with blood-gas or blood-count results. Thls database was intended as a source 
of :input data for an expert system. For such a function, data from one patient obtained 
with several analytical instruments should be automatically collected via a common 
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characteristic, e.g, the patient identification number. Because this number was inaccessible 
to the computer for privacy reasons, its use was precluded. 
7.2 Diagnostic support 
The automatization of clinical chemistry laboratories has led to an increase in capacity. 
The amount of data that is produced nowadays is too large to be interpreted by the 
clinical biochemist, in the way it was traditionally. Modem tecluriques of data processing 
offer the possibility of an automated interpretation of u'le analytical data, in which expert 
systems can play an important part. 
A current misconception is that this interpretation is an attempt to make a diagnosis. A 
diagnosis is usually based on information from various sources, e.g. clinical, chemical, 
radiological and microbiological information. Only ill exceptional cases is the information 
provided by the clinical chemistry laboratory sufficient to make a diagnosis. Therefore, 
the use of expert systems i..."l clinical chemistry is certainly not meant to provide 
diagnoses. 
There are, however, forms of interpretation which can be generated from only laboratory 
measurements. The recognition of a microcytic hypochromic anemia is not a diagnosis, 
but a conclusion which can be validly drawn from laboratory measurements. Providing 
information about the association of this observation with various diseases is still within 
the professional domain of clinical biochemistry. The challenge to clinical chemistry is 
to manoeuvre in the narrow strait between numbers and diagnoses to extract the 
maximum possible amount of information from the primary data. 
The enhanced L.lformation must not be forced upon the attending physician. However, the 
human miDd is not perfect at rememberi1"1g, and especially in overloaded consulting hours, 
details are at risk of being overlooked. Especially younger, less experienced physicians, 
which are usually ill charge at night or ill weekends when expert opinion is not readily 
available, will be well served with an interpretative report. In the opinion of the author, 
the ideal situation shonld bear resemblance to the traditional situation. The physician who 
wants to consnlt the clinical biochemist dials his mm1ber (pushes a button on his terminal) 
and is presented with diagnostic support, based on the resnlts from clinical chemistry 
measurements. In case of further questions, a personal contact should be preferred over 
an automatized explanation. 
73 Reasoning with uncertainty 
Expert system shells usually offer the possibility of reasoning with uncertaillty. This is 
done by the use of certainty factors, representing a degree of confmnation of a certain 
hypothesis, based on the combination of an a priori probability and new evidence. 
Shortliffe and Bucbanan introduced the certaillty factor as the difference between the 
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increased belief in a hypothesis and the increased disbelief in the same hypothesis, both 
as a result of the new evidence (5). 
At least four kinds of uncertainty can be found in the diagnostic process: 
1. Every measurement in clinical chemistry is subject to a small amount of analytical 
variation, which is known from quality control measurements (the preanalytical variation 
is UIL]{nown, but small). The analytical variation is always small compared to the 
variabilities mentioned hereafter. We have proposed a calculation of cer'"-ainty factors for 
this type of uncertainty (4). 
2. Every measurement has an amount of physiological variation withitl a healthy subject 
(circadian, seasonal, or irregular fluctuations). There is also an inter-individual variation 
between healthy subjects. These types of variation are usually not considered separately, 
and are included in the traditional reference range. 
3. Every parameter displays a pathological variation which is a resultant of the type of 
disease, its stage and the characteristics of the individual patient. 
4. Every diagnostic conclusion is subject to an amount of diagnostic uncertainty, caused 
by incomplete evidence and by the semi-quantitative nature of the evidence on which the 
diagnosis is based, and by the fact that many diseases have no pathognomonic 
characteristics. 
In well-defined situations (1 and 2), the use of the frequency ratio is recommended to 
calculate e.g. the probability that a given result is within its reference limits. The 
uncertainties mentioned in 3 and 4 are to a large extent unknown, or can only be 
Ltl3.ccurately estimated. It will be clear that the incorporation of these uncertainties b our 
expert systems would be a subjective and higP.ly complicated undertakir1g. Therefore we 
have refrained from the use of certainty factors. In LITIIOS, where the input data were 
very precise, L'he only uncertainty was a minor between-run shift of peak positions. 
7.4 Techniques 
Examples of the techniques, which can be used to produce enhanced information are the 
use of discriminant functions and pattern recognition. Pattern recognition techniques are 
usually based on Bayes' theorem. These techniques or the results thereof can be 
incorporated into expert systems to assist in the reasoning process. The bru..-rier to using 
these techriques is not their unavailability, but the lack of familiarity with them. The 
advantage in using these techniques is that clinical chemistry measurements are not 
considered as isolated results, but taking their interdependency into account. 
We have developed a multivariate model for acid-base measurements (6,7, ch. 5). From 
this model, the Mahalanobis distance can be calculated, which quantitatively characterizes 
the acid-base condition of the patient relative to t.fte mean of the hospital population. The 
monitoring of this distance offers the possibility to detenrine the relative stability of the 
acid-base disorder. In addition, this approach ensures a standardized interpretation. Its 
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performance in detecting acid-base disturbances was not grossly different from that of 
human experts (ch. 4). This model is currently being routinely used for acid-base 
monitoring in another hospital (Onze Lieve Vrouwe Gasthuis, Amsterdam). 
7.5 Programming tools 
Although the use of an expert system shell facilitates programming and reasoning with 
uncertainty, it is not obligatory. Many of the published systems have been written in 
conventional programming languages. In some cases systems have been developed using 
a shell, and were later translated into a conventional language to limit their cost and to 
speed up their performance (8). We have compared an expert system in LISP with a 
program in Turbo Pascal for the interpretation of X-ray diffractograms of urinary calculi, 
and we found that in this analytical sening both programs produce equal results in equal 
periods of time (ch. 3). 
The use of an expert system shell results in an expert system that is able to explain its 
line of reasoning. The advantage of this property is usually largely overestimated and it 
is of no use in a fully automated situation, because t.'lere is no need for an explanation. 
The main advantage of a shell is that it facilitates the development phase of an expert 
system. Decision rules can be easily added, removed, or rearranged. A trace option is 
available, which shows whether rules are applied or rejected, and in what sequence. Such 
a trace can be stored on disk and consultations can be rerun with a minor change in input 
data, to study the effect of such a change. 
7.6 Knowledge elicitation 
The development of expert systems necessitates its developers to think thoroughly about 
the knowledge domain. It is precisely this process which makes it painfully clear how 
liule hard-core knowledge there really is available. The knowledge needed to create such 
systems can be obtained in several ways. 
1. Knowledge can be extracted by interviewing experts on the subject, which is usually 
a very tedious procedure. The experts must have a consensus opinion, and the reasoning 
process has to be explained in great detail to the knowledge egineer (usually a layman) 
who is to implement the expertise. Clinical biochemists are in an advantageous situation 
because they are experts in their professioual domain and they are familiar with the use 
of computers for data communication and data processing. In this way they are in an 
ideal position to develop expert systems themselves. 
2. Knowledge can be obtained from large collections of data by numerical analysis. If 
demographic or clinical data are additionally available, the interpretative possibilities are 
increased. Unfortunately, the retrieval of clinical data usually meaus tedious work-up of 
patient records. 
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3. Knowledge can be obtained from the literature. This must be done with caution in 
order not to arrive at faulty conclusions (ch. 6, section 6.2.1). The author has been 
somewhat shocked at the amount of confusion in the literature over the interpretation of 
only one parameter (RDW) in three of the most common causes of anemia (ch. 6, section 
6.2.1.1). A clear picture in these cases can only be obtained by an overview of the 
literature, which accentuates the importance of such transversal studies. 
The lmowledge in LITHOS and HEMO was largely obtained from intervie~g experts (and 
from experiments in the case of LITHOS), whereas the knowledge in CHEMPA1H was 
obtained from the literature and from data analysis. 
7. 7 E:q>eriences with expert systems 
The development phase of expert systems can have useful spin-off. In the design of 
CHEMPA1H we found a large number of acid-base measurements which are unclassifiable 
by the traditional univariate classification. This led to the development of a multivariate 
model based on a patient population (ch. 4,5), in order to detect acid-base disturbances. 
The development of HEMO made us realize the relativity of the diagnostic value of the 
red cell indices and the importance of an accurate and precise reticulocyte count ( ch. 6, 
section 6.2.1). The use of LITHOS and CALCUU demonstrated that for the interpretation 
of X-ray diffractograms a conventional program (in Turbo Pascal) and an expert system 
perform equally well and comparable to the traditional method (ch. 3). 
The first version of the empty shell Personal Consultant was altered to enable manipulat-
ion of the system by USP programs, in order to avoid the use of programs in pseudo-
language with an English explanation. These would have occupied an undesirable 
proportion of the internal memory and thereby resulted in a slower expert system. The 
incorporation of LISP programs in the rnles mutilated the systems ability to explain its 
reasoning, because no translation of these programs into English could be given. 
However, the use of LISP provided us with all the facilities of a high level langnage, 
which proved to be indispensible in the construction of our expert systems. We have 
\VIitten programs which, during a consultation, alter the premise of certain rules, programs 
which automatically incorporate a debugging facility in another pro~ and even 
programs which on request construct the basic skeleton of other programs. These 
programs were incorporated in LITHOS, in order to extend the possibilities of the frrst 
version of the empty shell. 
However, we found our expert systems in USP to be rather slow. By writing the USP code 
in LITHOS more efficiently, we were able to double the speed of its execution. Nowadays 
there is a trend towards the use of faster shells in PROLOG or in C. In the development 
of Lrrnos, the 640 kb internal memory of the Olivetti M24 personal computer became 
a limitation when the system contained approximately 100 decision rnles. The frequent 
'garbage collections' of 30 seconds during which the system was locked while 'cleaning 
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up~ its memory were an annoying feature. In a newer version of the empty shell, the 
memory limitation is less severe because only the code which is directly needed is loaded 
into the internal memory. Also, the periods of garbage collection are much shorter and 
much less a nuisance. In view of the above arguments, the use of expert system shells in 
LISP is not recommended. 
We had an. unpleasant experience when learning that the manufacturer of the Personal 
Consultant empty shell did no longer support this product in Europe because lack of 
interest from the market. 
7.8 Advantages and disadvantages of expert systems 
Expert systems offer the continuous availability of expertise. They can save time for the 
human expert. They offer a standardized and logical approach to their problem area. They 
can be used in analytical situations (ch. 2), in plausibility control, in instrument 
troubleshooting, in diagnostic support (ch. 4,6), and in accelerated laboratory testing. 
A disadvantage is that in expert systems only incorporated variates will be considered, 
whereas the human mind tends to take additional information into account and to weigh 
the various factors according to the situation. This is a principal, yet not a decisive 
argument, because ru-,.y interpretative system can be expanded to include additional 
information. An equally indecisive argument is the fact that expert systems do not operate 
flawless, because this holds equally for human experts, as reported in the literature. 
7.9 Practical considerations 
The introduction of an expert system in its operational environment should be done 
gradually. By analogy to the introduction of a new analytical instrument, a period of time 
in which the old and the new system function parallel, is advantageous. In this way, 
confidence in its perfortnance will be created in all persons involved with its function. 
An expert system should be introduced only after thorough testing by its developers, in 
order to prevent premature scepticism. Its functioning should be continuously be 
monitored and evaluated as it should be, but seldom is, with human experts. 
The formalized knowledge in an expert system will be commercially attractive. A 
discussion on the caution that has to be applied in the transfer of expert systems, has been 
given in chapter l. In the new environment, the evaluation phase should be repeated, and 
maintenance and legal aspects should be strictly regulated. The incorporation of expert 
knowledge in analytical instruments for diaguostic purposes is a development in which 
clinical biochemists should participate. 
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7.10 Neural networks 
A further development in artificial intelligence is that of neural networks. These are 
programs for pattern recognition, which have the advantage of being more flexible than 
expert systems, since no decision tree is needed. Disadvantages are their inability to give 
advice, to explain their reasoning, to give selectively weight to certain conclusions, as 
well as their sensitivity to a correct choice of the training set and to· dimensioning. 
Comparisons have been made between the use of neural networks and of multivariate 
analysis in removal of effects of interfering compounds in colorimetry (9), in the 
diagnosis of breast carcinoma from laboratory data (!0), and in the grading of breast 
carcinoma (!!), in which both methods functioned equally well. In our opinion, neural 
networks are used preferably in situations where logical reasoning is difficult to apply, 
where no interaction is needed, and where there are subtle nuances to be differentiated. 
Recent research is directed towards an integrated use of expert systems and neural 
networks. 
7.11 Conclusions 
From the literature examples in this thesis it is clear that much research has already been 
done on the use of expert systems in clinical chemistry. It is also clear that research in 
the Netherlands in this area is lagging behind. We have shown that it is possible and 
desirable to develop expert systems that offer analytical or diagnostic assistance. The 
techniques to do this are unfamiliar in clinical chemistry in the Netherlands. A course of 
multivariate statistics and expert systems in the education of clinical biochemists is 
recommended to enable a widespread application of these techniques. 
It is hoped that this thesis has shown the need for interpretative reporting. The data, 
statistical techniques, and programs that incorporate such techniques are available. In 
short, all conditions are fulfilled to create a better information service, which ultimately 
will be advantageous to the patient. 
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SUMMARY 
Aim of this thesis 
The aim of this thesis is to investigate where and how expert systems can be used for 
information enhancement in clinical chemistry. It has been vvritten for a public of clinical 
biochemists with the hope to convert the existing scepticism about expert systems into 
enthousiasm. 
The content of this thesis is multifacetted by nature. In this aspect it differs from the 
usual type of thesis. The reader should realize, that precisely this multifacetted character 
is the leading thread of the thesis, and not an in-depth discussion of the diverse subjects. 
Chapter 1: Introduction 
In this chapter, the general aspects of expert systems and multivariate analysis are 
discussed. It is explained that the growing capacity of the clinical chemical laboratory 
enforces the need for automatic data interpretation. The traditional interpretation by 
comparison with a reference range is discussed, as well as its drawbacks when applicated 
to multi-analytical measurements. In this area, multivariate analysis can offer a number 
of advantages over the traditional approach. The need for information enhancement in 
clinical chemistry is illustrated with examples from the literature. 
A short review of the history of expert systems is given, and the languages, shells, 
structure and function of expert systems are discussed. Also, a discussion is given of 
some problems that can be encountered in developing expert systems. 
The juridical aspects of making and using expert systems are briefly explained. An 
extensive list of applications of expert systems in clinical chemistry is presented. Finally, 
a short discussion is given of future prospects in expert systems, and the scope of this 
thesis is given. 
Chapter 2: LITHOS 
In this chapter, an expert system is described which now is succesfully operative in the 
clinical chemistry laboratory. The expert system LITHOS interprets X-ray diffractograms 
of urinary calculi and reports the qualitative and quantitative compositions. The system 
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was developed at a time when analytical capacity had to be increased and human 
expertise was scarce. A description is given of the program and the flow of the inference 
process. For the interested reader, a detailed example of a complex consultation is 
available on request from the author of this thesis. 
Chapter 3: LITHOS and CALCULI 
This chapter is written in the form of a publication, because it is yet to be submitted. Two 
computer programs for the interpretation of X -ray diffractograms are compared. The frrst 
(LTI1!0S) is an expert system that has been described in chapter 2, and the other 
(CALCULI) has been developed at the Technical University Delft using a conventional 
programming language. The performance of both systems are compared to the results 
with the conventional Debije-Scherrer-Hull technique. The reproducibility of the 
analytical procedure including the interpretation by both systems has been investigated 
for three frequently occurring components. By further experiments, the main source of 
variation was found to be the analytical instrument, and not the sample preparation or the 
programs interpretation. A description is given how one weaker aspect in the interpreta-
tion of CALCULI could be improved. The problem of a new, unkno\VIl component is 
illustrated by the performance of LTI110S with urinary calculi from Indonesia. After a 
comparison of consultation times, the chapter closes with some fm.al remarks, describing 
the incorporation of both systems in the analytical procedure. When a consensus is 
reached by both programs, the result is reported to the attending physician. This is the 
majority of cases, which thus can be handled without human expertise. When there is a 
difference of opinion, the human interpretation of an X-ray film made with the Debije-
Scherrer-Hull camera has the fmal word. 
Chapter 4: CHEMPATH 
This chapter begins with an ample discussion of the nomenclature for acid-base disorders. 
When this aspect has not been clearly defmed, misunderstanding may arise easily. Several 
illustrative cases of acid-base disturbances are presented. A system of nomenclature is 
proposed, and tested with well-defmed literature cases. Knowledge of the anion gap 
would enhance the interpretative power of an automated system. Further handicaps are 
missing information (artificial ventilation, medication) and organizational factors. 
Examples taken from the literature are presented illustrating the need for intrepretative 
systems. An overview is given of existing interpretative systems for acid-base disorders 
and their characteristics. The expert system CHEMPATil for acid-base and electrolyte 
disturbances is described. 
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Chapter 5: Multivariate analysis 
This chapter describes the use of multivariate analysis to calculate reference ranges from 
patient data. These reference ranges can be used to signal early pathology and to detect 
laboratory error. A discussion is given of the advantages and disadvantages of this 
approach. The theory and calculation of these reference ranges is discussed. Results are 
presented of the calculation of patient -based reference ranges for acid-base parameters for 
different age groups. A discussion of these results in relation to the concept of setpoint 
is given. The use of the multivariate reference range is compared with the judgement of 
two clinicians. The chapter ends with a discussion of the multivariate changes of acid-
base parameters in time. 
Chapter 6: HEMO 
This chapter describes the development of an expert system for the interpretation of 
anemia. First, the diagnostic value of the MCV, RDW and reticulocyte count is discussed. 
An overview of RDW ranges in three pathological conditions is given, showing large 
overlap. A short discussion of discriminant functions is given. 
The development of HEMO is described, beginning with an analysis of the pattern of 
requests with policlinical patients. The structure of HEMO is described next. An overview 
is given of interpretative systems for anemia, with a focus on the work of four 
international groups. The need for interpretative reporting is illustrated with examples 
from the literature. Finally, the system is evaluated with a large set of patient data. 
Chapter 7: General discussion 
This last chapter presents a discussion of the application of expert systems in clinical 
chemistty. The functions that such systems can have in the clinical chemistty laboratory 
are mentioned, with examples. The character of the diagnostic support, that expert 
systems for clinical chemistry should give, is described. The sources of uncertainty in the 
diagnostic process are given, and it is explained why no use has been made of certainty 
factors. The techniques to produce enhanced information are mentioned and the use of 
an expert system shell is discussed. Several possible sources of knowledge for expert 
systems are mentioned. Experiences with expert systems are reported, as well as a 
discussion of advantages and disadvantages. After some practical considerations, a short 
section about neural networks is presented. The chapter closes with some conclusions and 
recommendations. 
SAMENVATTING 
Doe! van dit proefschrift 
Het doel van dit proefschrift is te onderzoeken waar en hoe expertsystemen kunnen 
worden gebruikt voor een verbeterde informatievoorziening vanuit de klinische chemie. 
Het is gescbreven voor een publiek van klinisch chernici in de hoop de bestaande scepsis 
ten aanzien van expertsystemen in enthousiasme om te zetten. 
De inhoud van dit proefschrift is van nature veelzijdig. In dit opzicht verschilt bet van 
bet normale type proefschrift. De lezer dient zich te realiseren, dat juist deze veelzijdig-
heid de rode draad door dit proefschrift vorrnt, en niet een diepgaande discussie van de 
verscheidene onderwerpen. 
Hoofdstuk 1: Inleiding 
In dit hoofdstuk worden de algemene aspecten van expertsystemen en multivariate analyse 
besproken. Er wordt uitgelegd dat de groeiende capaciteit van bet klinisch-chemisch 
laboratorium de noodzaak van autom.atische interpretatie van de gegevens doet toenemen. 
De traditionele interpretatie door vergelijki.ng met een referentiegebied wordt besproken, 
evenals de nadelen hiervan bij toepassing op verscbillende analyses. Hier kan de 
multivariate analyse een aantal voordelen bieden ten opzichte van de traditionele aanpak. 
De noodzaak van een verbeterde :informatievoorziening vanuit de klinische chernie wordt 
geillustreerd met voorbeelden uit de literatuur. 
Er wordt een kort overzicht van de geschiedenis van expertsystemen gegeven en de talen, 
shells, structuur en functies van expertsystemen worden besproken. Ook wordt een aantal 
problemen besproken die zich kunnen voordoen bij bet ontwikkelen van expertsystemen. 
De wettelijke aspecten van het maken en het gebruiken van expertsystemen worden kort 
van commentaar voorzien. In een uitgebreide lijst worden toepassingen van expert-
systemen in de klinische chemie venneld. Tenslotte wordt een korte discussie gegeven 
van de toekomstige ontwikkelingen op -het gebied van expertsystemen, alsmede een 
afbakening van het onderwerp van dit proefschrift. 
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Hoofdstuk 2: LITIIOS 
In dit hoofdstuk wordt een expertsysteem beschreven dat succesvol word! gebruikt in het 
klinisch-chemisch laboratorium. Het expertsysteem LTIHOS interpreteert rOntgen-
diffractogrammen van urinewegstenen en rapporteert de kwalitatieve en kwantitatieve 
samenstellingen. Het systeem is ontwikkeld toen de analytische capaciteit vergroot moest 
worden en de menselijke expertise schaars was. Er wordt een beschrij~g gegeven van 
het programma en van de redeneerwijze daarvan. Voor de geinteresseerde lezer is er een 
gedetailleerd voorbeeld van een ingewikkelde consultatie op verzoek verkrijgbaar bij de 
auteur van dit proefschrift. 
Hoofdstuk 3: LITHOS en CALCULI 
Dit hoofdstuk is geschreven in de vonn van een publicatie; als zodanig zal deze nag 
aangeboden worden. Er worden twee computerprogramma • s voor de interpretatie van 
r6ntgen-diffractogrammen vergeleken. Het eerste (LITHOS) is een expertsysteem dat in 
hoofdstuk 2 is beschreven, en het tweede (CALCULI) is ontwikkeld in een conventionele 
progranuneertaal aan de Teclmische Universiteit Delft. De verrichtingen van beide 
systemen worden vergeleken met de resultaten van de techniek volgens Debije, Scherrer 
en Hull. De reproduceerbaarheid van de analytische procedure, met inbegrip van de 
interpretatie van beide systemen, is onderzocht voor drie frequent voorkomende 
componenten. Uit verdere experimenten blijkt dat de belangrijkste bron van variatie het 
analytisch instrument is, en niet de monstervoorbereiding of de interpretatie van het 
programma. Er wordt beschreven hoe een zwakk.er aspect van de interpretatie van 
CALCULI kon worden verbeterd. Het probleem van een nieuwe, onbekende component 
wordt geillustreerd door het gedrag van LITHOS met urinewegstenen uit Indonesie. Na een 
vergelijking van consultatietijden sluit het hoofdstuk af met enkele opmerkingen omtrent 
de inbedding van beide systemen in de analytische procedure. Als de systemen een 
consensus bereiken word! het resultaat gerapporteerd aan de behandelende arts. Dit 
gebeurt in het grootste aantal van de gevallen, waardoor deze zonder menselijke expertise 
kunnen worden afgehandeld. Als de resultaten verschillen, geeft de interpretatie door een 
menselijke expert van een r6ntgenopname met de Debije-Scherrer-Hull-camera de 
doorslag. 
Hoofdstuk 4: CHEMPATH 
Dit hoofdstuk begint met een uitgebreide discussie van de nomenclatuur voor zuur-base-
afwijkingen. Indien dit aspect niet duidelijk is gedefinieerd kunnen er gemakkelijk 
nrisverstanden ontstaan. Verschillende illustratieve gevallen van zuur-base-afwijkingen 
worden gepresenteerd. Er wordt een systeem voor nomenclatuur voorgesteld en getest met 
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goed gedefmieerde casus uit de literatuur. Kennis van de grootte van de anion gap zou 
de interpretatieve kracht van een dergelijk geautom.atiseerd systeem kunnen vergroten. 
Verdere handicaps worden gevonnd door ontbrekende inforrnatie (kunstmatige 
beademing, medicatie) en door organisatorische factoren. 
Er worden voorbeelden uit de literatuur gegeven die de noodzaak van interpretatieve 
systemen illustreren. Ook word! een overzicht gegeven van de bestaande systemen voor 
zuur-base-afwijkingen en hun karakteristieken. 
Hoofdstuk 5: Multivariate analyse 
Dit hoofdsmk beschtijft het gebruik van multivariate analyse om referentiegebieden te 
berekenen uit patientengegevens. Deze referentiegebieden kwmen worden gebruikt om 
vroege pathologie te signaleren en om fouten van het laboratorium te detecteren. De voor-
en nadelen van deze benadering worden besproken, alsmede de theorie en de berekening 
van genoemde referentiegebieden. De resultaten worden gepresenteerd van een berekening 
van referentiegebieden voor zuur-base-parameters, op basis van patientengegevens voor 
verschillende leeftijdsgroepen. Deze resultaten worden besproken in samenhang met het 
begrip ~setpoint". Het gebruik van multivariate referentiegebieden wordt vergeleken met 
het oordeel van twee clinici. Het hoofdstuk eindigt met een bespreking van multivariate 
veranderingen van zuur-base-parameters in de tijd. 
Hoofdstuk 6: I!EMO 
Dit hoofdstuk beschrijft de ontwikkeling van een expertsysteem voor de interpretatie van 
anentie. De diagnostische waarde van de MCV, de RDW en het aantal reticulocyten 
wordt besproken. Een overzicht wordt gegeven van RDW-waarden in drie pathologische 
toestanden, waaruit een grote overlap blijkt. Er wordt een korte bespreking van 
discriminant-functies gegeven. 
De ontwikkeling van HEMO wordt beschreven, te beginnen met een analyse van de 
aanvraagpatronen bij poliklinische patienten. Vervolgens wordt de structuur van HEMO 
aangegeven. Een overzicht van interpretatieve systemen voor anemie wordt gegeven, met 
extra aandacht voor het werk van vier intemationale groepen. De noodzaak. van 
interpretatieve rapportage wordt geiDustreerd met voorbeelden uit de literatuur. Tenslotte 
wordt het systeem geevalueerd met een groot aantal patientengegevens. 
Hoofdstuk 7: Algemene discussie 
Dit laatste hoofdstuk biedt een algemene beschouwing over de toepassing van 
expertsystemen in de klinische chernie. De functies die dergelijke systemen in het 
klinisch-chemisch laboratOrium kunnen vervullen worden genoemd, met voorbeelden. Het 
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karakter van de diagnostische ondersteuning, die expertsystemen in de klinische chemie 
zouden moeten geven, wordt beschreven. 
De bronnen van onzekerheid in het diagnostisch proces worden genoemd en er wordt 
uitgelegd waarom er geen gebruik van ·certainty factors· is gemaakt. De technieken om 
verbeterde informatie te produceren worden genoemd en het gebruik van expertsysteem-
shells wordt besproken. V erschillende bronnen van kennis voor expertsystemen worden 
genoemd. De eigen ervaringen met expertsystemen worden vermeld, tezamen met een op-
somming van voor- en nadelen. Na enkele praktische opmerkingen volgt een kart onder-
dee! over neurale netwerken. Het hoofdstuk. sluit af met conclusies en aanbevelingen. 
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